Extreme obesity with alveolar hypoventilation

E4_OBESITYXTRMALV

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.2 Hospital discharge: ICD-9 — 2788A Cause of death: ICD-10 — E66.2 Cause of death: ICD-9 — 2788A 2 out of 7 registries used, show all original rules.	1457
4. Check minimum number of events None	1457
5. Include endpoints None	1457
6. Filter based on genotype QC (FinnGen only)	1457

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E66
Name in latin: Obesitas extrema cum hypoventilatione alveolari

NAME	E4_OBESITYXTRMALV
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E662
HD_ICD_9	2788A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E662
COD_ICD_9	2788A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Extreme obesity with alveolar hypoventilation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9083	4806	4240
Only index persons	8456	4518	3938
Unadjusted period prevalence (%)
Whole population	0.13	0.14	0.12
Only index persons	0.16	0.17	0.15
Median age at first event (years)
Whole population	62.01	62.99	60.88
Only index persons	62.08	62.87	61.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1457	808	649
Unadjusted period prevalence (%)	0.28	0.28	0.29
Median age at first event (years)	59.49	58.29	60.99

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1326: Matched controls
13261

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J96.1

ICD-10 Finland

Chronic respiratory failure

72.5

323.0

387

E66.01

ICD-10 Finland

Obesity due to excess calories

182.6

323.0

689

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

+∞

323.0

1325

E66.8

ICD-10 Finland

Other obesity

334.2

323.0

538

E66.00

ICD-10 Finland

Metabolic syndrome

66.4

323.0

448

101

E66.9

ICD-10 Finland

Obesity, unspecified

241.0

323.0

367

C03CA01

ATC

furosemide; systemic

11.4

323.0

882

1964

G47.3

ICD-10 Finland

Sleep apnoea

19.4

323.0

973

1648

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

9.5

283.1

747

1585

A10BA02

ATC

metformin; oral

8.3

263.7

803

2071

R5140

NOMESCO Finland

Monitoring the use of the aid

12.5

262.8

530

669

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

26.5

249.1

355

180

I50.9

ICD-10 Finland

Heart failure, unspecified

10.9

235.4

512

725

103

Kela drug reimbursment

Diabetes, insulin-treated

7.0

219.8

732

1984

E66

ICD-10 Finland

Obesity

32.8

215.8

288

111

T82

ICPC

Obesity

34.4

215.5

284

104

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2245.5

193.5

183

T90

ICPC

Diabetes non-insulin dependent

6.5

191.6

647

1701

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

20.2

186.7

290

181

XG466

NOMESCO Finland

Sleep oxymetry

21.4

184.9

281

164

215

Kela drug reimbursment

Diabetes, non-insulin-treated

6.1

183.8

656

1826

A46

ICD-10 Finland

Erysipelas

7.8

182.6

493

938

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

19.9

172.7

269

167

R06.0

ICD-10 Finland

Dyspnoea

5.6

166.9

647

1931

I10

ICD-10 Finland

Essential (primary) hypertension

5.4

155.4

1064

5682

WX725

NOMESCO Finland

Noninvasive ventilation

11.9

142.7

279

291

I50.0

ICD-10 Finland

Congestive heart failure

10.6

139.2

290

341

SPAT1262

SPAT

Handing over of treatment supplies

5.3

133.2

499

1353

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.9

133.1

565

1755

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

7.8

133.1

341

565

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

7.5

131.8

348

602

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

6.4

127.8

388

810

R03AC02

ATC

salbutamol; inhalant

4.2

126.2

957

5045

E11

ICD-10 Finland

Type 2 diabetes mellitus

5.7

125.8

428

1027

160

Kela drug reimbursment

exenatide

50.0

124.8

151

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

6.0

118.5

376

821

J45.9

ICD-10 Finland

Asthma, unspecified

4.9

115.9

456

1270

R03BB04

ATC

tiotropium bromide; inhalant

6.6

115.7

332

634

A10AE04

ATC

insulin glargine; parenteral

7.1

114.8

311

548

C03DA01

ATC

spironolactone; oral

6.5

113.2

330

642

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.0

105.9

403

1067

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

105.6

820

4110

H02AB06

ATC

prednisolone; systemic

3.6

104.7

855

4448

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

11.1

104.3

208

218

A10BJ02

ATC

liraglutide; parenteral

26.8

104.3

146

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

11.5

104.0

204

207

M04AA01

ATC

allopurinol; systemic

5.5

103.6

351

814

E66.0

ICD-10 Finland

Obesity due to excess calories

+∞

102.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.2

102.3

369

917

205

Kela drug reimbursment

Chronic hypertension

3.9

102.0

574

2192

WX722

NOMESCO Finland

PEEP

9.7

98.2

211

253

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.8

96.3

373

993

R03AK06

ATC

salmeterol and fluticasone; inhalant

4.8

95.6

369

978

A10BJ06

ATC

semaglutide; parenteral

14.7

90.7

157

120

A10BX07

ATC

[U] liraglutide; parenteral

59.8

89.7

105

J96.0

ICD-10 Finland

Acute respiratory failure

35.2

89.2

116

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

40.6

88.9

112

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.1

88.1

314

756

C07AB07

ATC

bisoprolol; oral

3.1

83.4

808

4426

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.4

83.3

551

2301

A10BH01

ATC

sitagliptin; oral

5.6

81.9

264

562

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

6.6

81.0

225

396

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

34.8

76.8

100

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.6

76.8

142

125

R60.0

ICD-10 Finland

Localized oedema

4.8

76.7

290

733

S97

ICPC

Chronic ulcer skin

7.7

76.7

189

279

A10BK03

ATC

empagliflozin; oral

6.7

76.6

211

366

J01FF01

ATC

clindamycin; systemic

3.2

75.6

534

2300

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

9.4

75.5

164

197

162

Kela drug reimbursment

liraglutide

53.5

75.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.6

74.5

410

1455

J01DB01

ATC

cefalexin; oral

4.2

72.0

1196

9089

A10BB12

ATC

glimepiride; oral

6.4

71.5

202

361

SPAT1254

SPAT

Administration of medicine

4.1

69.0

311

924

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.2

68.1

231

514

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.0

67.3

316

972

R02

ICPC

Shortness of breath/dyspnoea

4.1

66.2

291

842

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.5

66.1

367

1296

I50

ICD-10 Finland

Heart failure

12.2

65.8

123

110

N02AX02

ATC

tramadol; systemic, rectal

2.7

64.2

706

3920

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

5.8

63.6

196

388

J01MA12

ATC

levofloxacin; systemic

3.3

63.2

380

1420

A28

ICPC

Limited function/disability NOS

3.9

63.0

303

946

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

62.4

523

2450

L28

ICPC

Limited function/disability (L)

3.7

62.3

318

1042

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

62.2

564

2774

B03BA03

ATC

hydroxocobalamin; parenteral

6.2

61.3

176

318

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.1

60.5

264

753

N05AH04

ATC

quetiapine; oral

3.5

60.1

328

1131

SPAT1263

SPAT

Sampling

2.6

59.1

686

3863

A08AB01

ATC

orlistat; oral

39.1

58.5

N06AX16

ATC

venlafaxine; oral

3.7

57.0

286

917

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.3

56.6

332

1203

J96.9

ICD-10 Finland

Respiratory failure, unspecified

32.1

55.2

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.6

54.7

286

946

B01AA03

ATC

warfarin; systemic

3.1

54.2

356

1395

N05AA02

ATC

levomepromazine; systemic

6.8

53.6

142

229

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

9.8

53.6

112

124

M10.9

ICD-10 Finland

Gout, unspecified

5.3

53.1

173

363

N02BE01

ATC

paracetamol; systemic, rectal

3.8

52.5

1219

9931

A10BX04

ATC

[U] exenatide; parenteral

44.7

52.1

A10AE05

ATC

insulin detemir; parenteral

6.3

52.0

147

259

SPAT1301

SPAT

No procedures

2.6

51.9

524

2668

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.5

51.6

163

329

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.9

51.6

241

722

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.4

51.0

203

525

QBJ30

NOMESCO Finland

Correction of abdominal apron

60.5

49.8

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

8.9

49.8

110

134

R06.2

ICD-10 Finland

Wheezing

7.1

49.4

127

196

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.8

49.4

388

1693

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

7.9

49.3

117

160

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

49.3

N03AX16

ATC

pregabalin; oral

2.7

49.2

425

1964

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.0

48.9

126

195

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

47.7

369

1590

C09AA02

ATC

enalapril; systemic

2.9

47.6

355

1494

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.8

47.1

169

392

WX723

NOMESCO Finland

CPAP therapy

7.1

47.0

120

183

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.1

46.7

297

1122

C08CA01

ATC

amlodipine; oral

2.4

46.4

565

3127

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.4

46.3

260

898

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.3

45.9

186

487

A02BC02

ATC

pantoprazole; systemic

2.4

45.8

952

6837

L17

ICPC

Foot/toe symptom/complaint

2.6

45.4

416

1973

C09AA05

ATC

ramipril; oral

2.6

44.2

417

2005

SPAT1229

SPAT

Assessment of need for aid

4.2

44.1

184

494

N02AA05

ATC

oxycodone; systemic

3.1

43.7

272

1007

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.3

43.5

243

832

OAB72

NOMESCO Finland

Weight control and weight loss guidance

49.1

43.2

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

9.9

43.2

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

10.5

43.1

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

+∞

42.9

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

42.9

N05AF03

ATC

chlorprothixene; systemic

8.0

42.9

100

133

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

42.6

220

709

B01AB05

ATC

enoxaparin; parenteral

2.4

42.3

495

2655

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

42.1

705

4484

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

6.9

41.7

108

168

A08

ICPC

Swelling

6.3

41.5

116

200

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

41.4

602

3575

J45.1

ICD-10 Finland

Nonallergic asthma

4.4

40.8

160

404

M79.6

ICD-10 Finland

Pain in limb

2.3

40.5

552

3169

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

40.0

225

771

J46

ICD-10 Finland

Status asthmaticus

8.6

39.9

110

A06AD11

ATC

lactulose; oral

3.1

39.9

254

951

SPAT1255

SPAT

Intravenous administration of medicine

4.3

39.9

159

408

N05AX08

ATC

risperidone; systemic

4.2

38.9

160

422

A10BJ01

ATC

exenatide; parenteral

52.8

38.8

S76

ICPC

Skin infection other

5.1

38.7

128

270

N05BA04

ATC

oxazepam; oral

2.5

38.7

394

1948

R60.9

ICD-10 Finland

Oedema, unspecified

5.3

38.3

122

247

R03AK07

ATC

formoterol and budesonide; inhalant

2.6

37.9

331

1503

J01DA01

ATC

[U] cefalexin; systemic

2.1

37.4

884

6391

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

37.2

464

2530

WX780

NOMESCO Finland

Remote monitoring CPAP

5.7

37.2

111

208

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.8

37.1

170

493

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

37.1

355

1692

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

4.0

37.1

161

446

A10BH05

ATC

linagliptin; oral

5.4

36.8

116

232

N05AX12

ATC

aripiprazole; systemic

6.4

36.6

100

167

C10AA01

ATC

simvastatin; oral

2.1

36.2

627

3946

N06AX12

ATC

bupropion; oral

4.7

36.1

129

296

N05AH03

ATC

olanzapine; systemic

4.5

35.6

134

324

N06AB04

ATC

citalopram; systemic

2.5

35.4

348

1677

SPAT1310

SPAT

Counselling related to known health issue

2.2

35.3

488

2775

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.8

35.2

161

466

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.6

34.9

129

306

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

10.5

34.9

E0000UV

ATC

2.1

34.6

563

3431

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

34.3

201

705

N06AX21

ATC

duloxetine; oral

3.1

34.2

205

728

R03BA05

ATC

fluticasone; inhalant

2.5

34.2

305

1391

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.1

34.2

140

367

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

34.0

453

2523

A12BA01

ATC

potassium chloride; oral

5.4

33.7

106

211

358

Kela drug reimbursment

liraglutide

51.5

33.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.4

33.3

173

554

N06AB03

ATC

fluoxetine; oral

2.9

33.3

230

900

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

33.2

623

4008

SPAT1260

SPAT

Consultation of another employee

2.5

33.0

299

1371

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

32.8

722

4940

WX730

NOMESCO Finland

Conventional respirator

10.3

32.6

N06AA09

ATC

amitriptyline; systemic

3.1

32.4

200

724

N03AX09

ATC

lamotrigine; oral

5.1

32.3

107

226

SPAT1312

SPAT

General health counselling

2.1

32.3

464

2660

S18

ICPC

Laceration/cut

2.0

32.2

611

3928

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.7

32.2

132

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

5.5

31.9

190

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.9

31.5

107

232

A10BH02

ATC

vildagliptin; oral

8.9

31.4

A10BG03

ATC

pioglitazone; oral

7.8

31.4

100

R03DA04

ATC

theophylline; systemic, rectal

4.8

31.4

109

242

A10BK01

ATC

dapagliflozin; oral

5.0

31.0

103

218

XG410

NOMESCO Finland

Flow-volume spirometry

5.0

30.9

103

219

SPAT1240

SPAT

Therapeutic discussion

3.2

30.7

176

603

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.6

30.6

112

263

C01AA05

ATC

digoxin; systemic

3.9

30.4

134

374

M54.5

ICD-10 Finland

Low back pain

2.1

30.4

481

2854

A41.9

ICD-10 Finland

Sepsis, unspecified

5.3

30.2

189

C09BA02

ATC

enalapril and diuretics; systemic

3.4

30.2

160

519

J01AA02

ATC

doxycycline; systemic

2.2

30.2

1075

8763

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.2

30.1

121

311

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.8

30.0

104

231

K07

ICPC

Swollen ankles/oedema

5.0

29.9

100

213

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

18.3

29.8

R03AK08

ATC

formoterol and beclometasone; inhalant

5.3

29.8

188

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.3

29.4

325

1640

R03BA01

ATC

beclometasone; inhalant

2.6

29.3

240

1035

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.9

29.2

195

741

J01CE08

ATC

benzathine benzylpenicillin; parenteral

17.0

29.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

29.0

226

945

SPAT1281

SPAT

Other administrative function

3.3

28.9

158

524

J45.8

ICD-10 Finland

Mixed asthma

5.8

28.9

152

J45

ICD-10 Finland

Asthma

3.0

28.9

179

649

C03AA03

ATC

hydrochlorothiazide; oral

3.0

28.9

178

643

SPAT1211

SPAT

Application of soft bandage

3.2

28.8

166

570

J01FA06

ATC

roxithromycin; oral

2.0

28.8

582

3779

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.2

28.8

191

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.6

28.7

103

237

C08CA13

ATC

lercanidipine; oral

2.7

28.7

223

933

R50.9

ICD-10 Finland

Fever, unspecified

2.7

28.6

227

957

N06AB10

ATC

escitalopram; oral

2.4

28.6

293

1421

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

4.5

28.2

105

251

R53

ICD-10 Finland

Malaise and fatigue

2.3

27.8

299

1482

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.8

27.8

N05BA01

ATC

diazepam; systemic, rectal

2.6

27.7

231

1003

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.6

27.7

225

962

SPAT1139

SPAT

Nutrition survey

5.7

27.7

152

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

6.4

27.6

121

E000001

ATC

2.3

27.5

313

1593

SPAT1234

SPAT

Support of social functional capacity

4.3

27.5

105

257

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

27.1

243

1097

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

27.1

200

807

A10BD07

ATC

metformin and sitagliptin; systemic

4.6

27.0

228

N05CD07

ATC

temazepam; oral

2.6

26.7

214

907

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.8

26.7

193

770

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

4.3

26.7

102

250

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.3

26.4

144

477

R03DC03

ATC

montelukast; oral

2.4

26.3

248

1149

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

8.9

26.2

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

26.1

419

2467

C02AC05

ATC

moxonidine; oral

4.6

25.7

211

N05CF01

ATC

zopiclone; oral

2.0

25.7

454

2772

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

25.6

167

622

RK320

NOMESCO Finland

13.7

25.6

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

7.3

25.6

B81

ICPC

Anaemia vit B12/folate deficiency

4.7

25.4

204

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

25.4

307

1599

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.8

25.4

191

207

Kela drug reimbursment

Chronic arrhythmias

2.5

25.3

219

968

WX110

NOMESCO Finland

Local anesthesy

1.9

25.2

916

7190

N18.8

ICD-10 Finland

Other chronic renal failure

6.6

25.1

105

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

25.1

218

966

A10BG02

ATC

rosiglitazone; oral

11.3

25.0

SPAT1104

SPAT

Monitoring of emergency patient

3.4

24.8

129

411

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

24.8

129

412

N03AG01

ATC

valproic acid; systemic, rectal

3.6

24.7

119

357

WX892

NOMESCO Finland

Monitored bed care

3.2

24.7

140

475

N05AB03

ATC

perphenazine; systemic, rectal

4.3

24.7

229

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.2

24.6

161

N06AB06

ATC

sertraline; oral

2.7

24.6

178

710

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

24.5

216

962

C01DA14

ATC

isosorbide mononitrate; oral

2.5

24.3

208

912

R06.5

ICD-10 Finland

Mouth breathing

2.9

24.2

163

619

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

24.2

194

821

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

4.0

24.1

259

J01MA14

ATC

moxifloxacin; systemic

2.9

24.1

160

604

I50.1

ICD-10 Finland

Left ventricular failure

4.2

24.1

235

XCK10

NOMESCO Finland

Photography of fundus of eye

2.8

23.9

169

662

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

3.8

23.9

104

287

F34.1

ICD-10 Finland

Dysthymia

5.1

23.9

158

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

6.5

23.9

101

A10BB01

ATC

glibenclamide; oral

5.1

23.7

155

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.2

23.7

133

448

RD210

NOMESCO Finland

9.1

23.7

B01AF02

ATC

apixaban; oral

2.8

23.7

161

617

C07AB02

ATC

metoprolol; systemic

2.2

23.6

295

1555

D07AC01

ATC

betamethasone; topical

1.9

23.5

476

3031

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

11.3

23.5

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.2

23.5

226

N05BA06

ATC

lorazepam; systemic, sublingual

3.9

23.5

101

276

K77

ICPC

Heart failure

7.1

23.1

E66.1

ICD-10 Finland

Drug-induced obesity

+∞

23.0

K04.0

ICD-10 Finland

Pulpitis

2.8

23.0

157

603

J01DA09

ATC

[U] cefadroxil; inhalant, oral

2.0

22.8

387

2305

N06AX11

ATC

mirtazapine; oral

1.9

22.8

445

2789

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

22.8

510

3355

S10

ICPC

Boil/carbuncle

3.7

22.8

103

294

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

22.6

257

1293

SPAT1231

SPAT

Assessment of adjustments needed in living environment

8.1

22.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

22.6

242

1186

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.6

22.4

183

AA1AD

NOMESCO Finland

CT of head and brain

2.0

22.4

337

1911

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

22.4

376

2226

D01AC02

ATC

miconazole; topical

2.9

22.3

141

515

A10BX01

ATC

guar gum; systemic

4.7

22.2

171

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

53.0

22.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.2

22.1

141

J01CF05

ATC

flucloxacillin; systemic

4.3

22.1

210

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

21.9

112

353

SPAT1216

SPAT

Assessment of functional ability

2.3

21.7

223

1068

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

21.7

548

3733

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

9.3

21.7

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.1

21.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

7.1

21.6

K08.3

ICD-10 Finland

Retained dental root

3.1

21.6

125

431

A08AA10

ATC

sibutramine; oral

31.7

21.5

N03AX12

ATC

gabapentin; oral

2.2

21.4

239

1192

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.1

21.3

101

N06AX03

ATC

mianserin; oral

3.6

21.2

285

R95

ICPC

Chron obstructive pulmonary disease

5.2

21.2

135

WX721

NOMESCO Finland

Oxygen concentrator therapy

50.9

21.2

N03AE01

ATC

clonazepam; systemic

3.3

21.1

111

357

A04

ICPC

Weakness/tiredness general

2.5

21.1

183

806

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.2

21.0

205

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

21.0

252

1295

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

6.2

20.9

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

20.9

187

837

R03BA02

ATC

budesonide; inhalant

2.1

20.8

257

1338

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

8.9

20.7

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

10.5

20.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.7

20.5

256

A10BJ05

ATC

dulaglutide; parenteral

18.6

20.5

M10.0

ICD-10 Finland

Idiopathic gout

4.8

20.2

147

M10

ICD-10 Finland

Gout

3.8

20.1

239

Z02.7

ICD-10 Finland

Issue of medical certificate

3.2

20.0

112

374

L03

ICPC

Low back symptom/complaint

1.9

20.0

331

1939

SPAT1243

SPAT

Psychiatric/psychological examination

5.9

19.9

N19

ICD-10 Finland

Unspecified kidney failure

4.9

19.8

141

H02AB07

ATC

prednisone; oral

2.2

19.8

217

1068

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

19.7

136

525

H3600, E113

ICD-10 Finland

7.9

19.7

SPAT1094

SPAT

Continuous Positive Airway Pressure

8.1

19.6

C08CA02

ATC

felodipine; oral

2.7

19.6

147

595

H03AA01

ATC

levothyroxine sodium; systemic

1.9

19.2

328

1936

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.9

19.1

124

461

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.7

18.9

144

F61.0

ICD-10 Finland

Mixed personality disorders

8.1

18.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

18.8

129

494

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

18.8

511

3516

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.7

18.8

243

A10AB06

ATC

insulin glulisine; parenteral

11.2

18.7

P76

ICPC

Depressive disorder

3.4

18.6

282

WX872

NOMESCO Finland

Intensive care

3.3

18.6

299

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

18.6

162

713

J20

ICD-10 Finland

Acute bronchitis

2.6

18.6

148

621

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

18.4

296

1707

C09CA01

ATC

losartan; oral

1.9

18.4

341

2069

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

18.4

149

628

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

18.4

124

472

U04

ICPC

Incontinence urine

3.8

18.3

222

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.5

18.3

270

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

18.2

367

2292

TLC00

NOMESCO Finland

Insertion of intrauterine device

3.4

18.2

276

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

18.1

886

7188

L14

ICPC

Leg/thigh symptom/complaint

2.8

18.1

121

455

F32.1

ICD-10 Finland

Moderate depressive episode

3.5

18.1

261

S06

ICPC

Rash localized

3.3

18.1

305

SPAT1172

SPAT

Guidance concerning hydration

6.2

18.1

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.7

18.1

135

543

SPAT1097

SPAT

Recording of ECG

2.1

18.1

226

1177

P03

ICPC

Feeling depressed

2.9

18.1

117

433

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

17.9

163

731

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.2

17.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

17.8

317

1897

WX781

NOMESCO Finland

Remote monitoring, noninvasive ventilation

67.5

17.7

GX2C5

NOMESCO Finland

Short-lasting oximetry

67.5

17.7

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.7

17.7

218

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

10.5

17.7

A01

ICPC

Pain general/multiple sites

2.8

17.7

120

458

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

17.7

514

3589

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

17.7

127

502

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

17.7

359

2245

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.6

17.6

S29

ICPC

Skin symptom/complaint other

2.1

17.6

234

1249

EBA00

NOMESCO Finland

Extraction of tooth

1.7

17.6

436

2904

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

17.5

270

1526

L30.4

ICD-10 Finland

Erythema intertrigo

8.5

17.5

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

17.5

106

377

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.4

17.4

177

Kela drug reimbursment

Insulin glargine 300 U / ml

6.9

17.3

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

14.1

17.3

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

17.2

370

2351

E87.6

ICD-10 Finland

Hypokalaemia

4.4

17.1

145

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

17.1

168

785

R03AC03

ATC

terbutaline; inhalant

2.1

17.0

205

1052

N05AD01

ATC

haloperidol; systemic

4.4

16.9

147

H02AB04

ATC

methylprednisolone; systemic

2.1

16.8

215

1128

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

16.8

227

1221

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.4

16.7

N04AA02

ATC

biperiden; systemic

5.5

16.7

P06

ICPC

Sleep disturbance

2.5

16.7

140

603

RK110

NOMESCO Finland

11.8

16.6

A02BC01

ATC

omeprazole; systemic

1.8

16.4

366

2346

D09AB01

ATC

zinc bandage without supplements; topical

5.7

16.4

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.8

16.4

TQW80

NOMESCO Finland

Local dermatologic skincare

4.5

16.4

133

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

7.0

16.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.4

16.2

N05AN01

ATC

lithium; oral

4.7

16.2

121

L15

ICPC

Knee symptom/complaint

1.9

16.1

281

1657

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.6

16.1

126

RK323

NOMESCO Finland

18.8

16.0

R06AE07

ATC

cetirizine; oral

1.6

16.0

544

3939

R4190

NOMESCO Finland

Nutritional therapy

4.6

16.0

127

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

16.0

109

417

L16

ICPC

Ankle symptom/complaint

2.4

15.9

140

617

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.2

15.9

151

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

15.9

102

376

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

15.9

138

606

J01CA04

ATC

amoxicillin; systemic

1.7

15.9

1025

8802

R96

ICPC

Asthma

2.5

15.8

131

559

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

15.8

153

709

R28

ICPC

Limited function/disability (R)

8.5

15.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

15.8

168

812

D07BC01

ATC

betamethasone and antiseptics; topical

2.1

15.7

183

922

K02.1

ICD-10 Finland

Caries of dentine

1.6

15.7

706

5496

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

15.6

290

1748

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.5

15.5

127

540

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

15.5

196

1023

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

15.4

336

2133

D07AC13

ATC

mometasone; topical

1.7

15.4

381

2514

N17.8

ICD-10 Finland

Other acute renal failure

7.6

15.2

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

7.6

15.2

WX882

NOMESCO Finland

High dependency care

4.5

15.1

125

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

15.1

174

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

15.1

130

568

T83

ICPC

Overweight

6.2

15.1

AA40B

NOMESCO Finland

14.1

15.0

R04.0

ICD-10 Finland

Epistaxis

2.7

15.0

107

419

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

15.0

341

2189

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

14.9

443

3076

R05FB02

ATC

cough suppressants and expectorants

1.6

14.9

496

3549

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.9

14.9

166

N30.0

ICD-10 Finland

Acute cystitis

2.1

14.8

183

943

Z08

ICPC

Social welfare problem

7.6

14.7

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

14.7

105

412

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

25.3

14.7

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.2

14.6

R03AC13

ATC

formoterol; inhalant

3.1

14.6

275

C08DB01

ATC

diltiazem; oral

3.2

14.6

261

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.7

14.6

107

R03BB01

ATC

ipratropium bromide; inhalant

3.6

14.5

185

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

14.4

181

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.1

14.4

141

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

14.4

145

682

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

14.4

241

ZZA00

NOMESCO Finland

Split skin graft

4.2

14.4

132

N05AH02

ATC

clozapine; systemic

4.9

14.3

N03AX11

ATC

topiramate; oral

4.5

14.3

114

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

14.2

334

P29

ICPC

Psychological sympt/compl other

3.0

14.2

282

AN1

Coronary angiography

2.1

14.1

161

801

GX2D5

NOMESCO Finland

Sleep oximetry

14.6

14.1

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.5

14.0

M02AA07

ATC

piroxicam; topical

1.6

14.0

478

3434

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

14.0

101

400

N05BA02

ATC

chlordiazepoxide; systemic

4.5

14.0

112

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

14.0

247

1458

WZC30

NOMESCO Finland

Teaching

2.0

13.9

187

999

N07BB01

ATC

disulfiram; oral

3.1

13.9

268

R03AC12

ATC

salmeterol; inhalant

3.1

13.8

248

UKC02

NOMESCO Finland

Cystoscopy

1.9

13.8

210

1176

J01MA02

ATC

ciprofloxacin; systemic

1.6

13.8

503

3667

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

13.7

I48.2

ICD-10 Finland

Chronic atrial fibrillation

4.4

13.7

114

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

13.7

115

494

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

13.7

359

2394

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.2

13.7

S22

ICPC

Nail symptom/complaint

2.8

13.6

326

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.0

13.6

139

E86

ICD-10 Finland

Volume depletion

4.8

13.6

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

13.6

T92

ICPC

Gout

4.9

13.5

SPAT1167

SPAT

Insertion of urinary catheter

3.9

13.5

150

T07

ICPC

Weight gain

10.2

13.5

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

13.5

337

2215

AA43B

NOMESCO Finland

141.3

13.5

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

13.5

259

1570

P99

ICPC

Psychological disorders other

4.2

13.4

122

E87.5

ICD-10 Finland

Hyperkalaemia

6.0

13.4

N05BE01

ATC

buspirone; oral

4.1

13.3

132

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

5.0

13.3

D01AC03

ATC

econazole; topical

2.7

13.3

361

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

13.3

213

1216

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.8

13.3

320

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.5

13.2

106

444

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.4

13.2

P01AB01

ATC

metronidazole; oral, rectal

1.6

13.2

508

3745

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.8

13.2

328

B01AB10

ATC

tinzaparin; parenteral

2.4

13.1

109

468

SPAT1251

SPAT

Organisation of medication

3.4

13.1

186

M54

ICD-10 Finland

Dorsalgia

2.1

13.0

147

729

R60.1

ICD-10 Finland

Generalized oedema

16.9

13.0

S01

ICPC

Pain/tenderness of skin

3.1

13.0

237

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.6

12.9

380

C09DA01

ATC

losartan and diuretics; oral

2.1

12.9

155

788

E000003

ATC

2.9

12.8

277

L60.0

ICD-10 Finland

Ingrowing nail

3.1

12.7

243

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

9.8

12.7

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.3

12.7

127

595

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.9

12.7

M01AX17

ATC

nimesulide; oral

1.7

12.7

326

2154

SGA01

NOMESCO Finland

Tooth opening as first aid

1.9

12.7

205

1172

E000006

ATC

2.4

12.7

106

456

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.9

12.6

139

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

12.6

113

503

C02EA02

ATC

3.2

12.5

220

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.5

12.5

166

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.5

12.5

414

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

12.5

221

C03BA11

ATC

indapamide; oral

3.9

12.4

131

N05BA12

ATC

alprazolam; oral

2.1

12.4

143

716

C09DA03

ATC

valsartan and diuretics; oral

2.9

12.4

273

M79.7

ICD-10 Finland

Fibromyalgia

3.6

12.3

158

S17

ICPC

Abrasion/scratch/blister

4.7

12.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.7

12.2

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.5

12.2

N05AC02

ATC

thioridazine; oral

4.3

12.2

104

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

12.2

300

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

12.2

188

1053

K92.1

ICD-10 Finland

Melaena

2.8

12.1

294

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.2

12.1

XA421

NOMESCO Finland

Nocturnal polygraphy

12.5

12.1

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.3

12.1

105

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.1

12.0

WX290

NOMESCO Finland

Other blockade of nerve

1.5

12.0

531

4016

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.4

12.0

177

SPAT1125

SPAT

Stoma care and guidance

5.4

12.0

XG460

NOMESCO Finland

Short time oxymetry

5.8

12.0

M48.0

ICD-10 Finland

Spinal stenosis

2.0

11.9

160

851

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.1

11.9

211

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

11.9

173

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.4

11.9

173

M01AE02

ATC

naproxen; oral, rectal

1.5

11.8

698

5628

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

11.8

132

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.9

11.8

UJF32

NOMESCO Finland

Coloscopy

1.6

11.8

330

2229

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

14.8

11.8

K78

ICPC

Atrial fibrillation/flutter

2.4

11.8

100

433

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

11.7

315

2106

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.5

11.7

G04BD04

ATC

oxybutynin; oral, transdermal

2.8

11.7

290

A10BD03

ATC

metformin and rosiglitazone; systemic

5.4

11.7

J98.6

ICD-10 Finland

Disorders of diaphragm

12.7

11.6

D07XC01

ATC

betamethasone, combinations; topical

2.0

11.6

165

898

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

11.6

204

1197

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

5.2

11.6

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

11.2

11.5

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.8

11.5

130

N02AC04

ATC

dextropropoxyphene; oral

3.2

11.5

194

SPAT1151

SPAT

Treatment of major wounds

5.7

11.5

EBA10

NOMESCO Finland

Surgical removal of tooth

2.1

11.4

136

688

M09AX01

ATC

hyaluronic acid; parenteral

2.7

11.4

288

SPAT1276

SPAT

Outlining of treatment with patient or their family members

4.2

11.4

102

A11CC03

ATC

alfacalcidol; systemic

4.4

11.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.9

11.3

117

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

11.3

246

G04BD12

ATC

mirabegron; oral

2.1

11.3

135

687

L73.2

ICD-10 Finland

Hidradenitis suppurativa

7.3

11.3

H3601, E113

ICD-10 Finland

4.8

11.2

B01AB04

ATC

dalteparin; parenteral

2.7

11.2

297

JN4AD

NOMESCO Finland

Body CT examination

2.2

11.2

112

528

R05

ICPC

Cough

1.7

11.1

265

1708

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

4.0

11.1

114

SPAT1252

SPAT

Overall medication plan or its review

2.4

11.1

428

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

6.5

11.1

N06AB05

ATC

paroxetine; oral

2.5

11.1

381

SPAT1377

SPAT

Polysomnography

3.1

11.1

194

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

11.1

200

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

11.0

135

691

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.8

11.0

120

N06AA12

ATC

doxepin; systemic

2.6

11.0

319

XF640

NOMESCO Finland

3.5

11.0

146

N05AA01

ATC

chlorpromazine; systemic, rectal

4.7

10.9

R55

ICD-10 Finland

Syncope and collapse

2.0

10.9

137

711

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

10.9

180

D01AE15

ATC

terbinafine; topical

2.3

10.8

432

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.4

10.8

1276

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.5

10.8

143

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.5

10.8

362

RK250

NOMESCO Finland

9.7

10.8

5CM18

NOMESCO Finland

18.0

10.7

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.0

10.7

209

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

10.7

219

1348

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

10.6

203

1224

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

10.6

115

560

A02BC05

ATC

esomeprazole; systemic

1.5

10.6

508

3887

S80.0

ICD-10 Finland

Contusion of knee

2.5

10.6

353

M01AB51

ATC

indometacin, combinations; oral, rectal

4.0

10.5

105

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.8

10.5

120

C07AG02

ATC

carvedilol; oral

2.5

10.5

345

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

10.5

221

1371

F61

ICD-10 Finland

Mixed and other personality disorders

14.3

10.5

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.9

10.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

10.4

120

599

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.8

10.4

E61.1

ICD-10 Finland

Iron deficiency

6.9

10.4

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

10.4

114

560

D07AA02

ATC

hydrocortisone; topical

1.9

10.4

161

903

SPAT1051

SPAT

Guidance regarding sleep disorders

5.0

10.4

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.8

10.3

112

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

10.7

10.3

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

8.9

10.3

-56

ICPC

Dressing/pressure/compress/tamponade

4.8

10.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

10.3

108

519

LCA06

NOMESCO Finland

Biopsy of endometrium

1.9

10.3

153

846

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

10.3

171

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

18.9

10.3

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.4

10.2

144

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

10.2

197

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.6

10.2

B80

ICPC

Iron deficiency anaemia

4.2

10.2

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

10.2

129

670

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.1

10.2

A10BX09

ATC

[U] dapagliflozin; oral

6.3

10.2

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.5

10.2

K02.2

ICD-10 Finland

Caries of cementum

2.8

10.2

242

N05AF01

ATC

flupentixol; systemic

4.3

10.1

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

8.0

10.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.9

10.1

N06AA04

ATC

clomipramine; systemic

4.2

10.1

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

10.1

142

769

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.6

10.1

125

D11

ICPC

Diarrhoea

2.0

10.0

128

667

A07AA02

ATC

nystatin; oral

2.4

10.0

383

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.9

10.0

105

Z72.0

ICD-10 Finland

Tobacco use

3.8

10.0

110

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.2

10.0

169

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

10.0

451

C10AA05

ATC

atorvastatin; oral

1.5

10.0

469

3557

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

9.9

111

A10AE06

ATC

insulin degludec; parenteral

3.5

9.9

132

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

9.9

139

753

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

9.9

350

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.5

9.9

127

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

5.1

9.9

J01FA15

ATC

telithromycin; oral

2.0

9.9

137

739

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

9.9

135

724

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

9.9

182

P72

ICPC

Schizophrenia

4.1

9.9

N05AF05

ATC

zuclopenthixol; systemic

5.5

9.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.5

9.8

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.5

9.8

133

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.1

9.8

D75.1

ICD-10 Finland

Secondary polycythaemia

8.8

9.8

F60.8

ICD-10 Finland

Other specific personality disorders

9.6

9.8

R03AK11

ATC

formoterol and fluticasone; inhalant

3.6

9.8

118

TK800

NOMESCO Finland

Hemodialysis

4.0

9.7

N06AX26

ATC

vortioxetine; oral

2.6

9.7

290

F33

ICD-10 Finland

Recurrent depressive disorder

4.7

9.7

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.4

9.7

ZXA10

NOMESCO Finland

Bilateral

1.7

9.7

230

1475

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

3.6

9.7

119

M15

ICD-10 Finland

Polyarthrosis

2.7

9.7

249

E68

ICD-10 Finland

Sequelae of hyperalimentation

55.4

9.7

YHMAS

NOMESCO Finland

6.9

9.6

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

9.6

250

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.6

9.6

120

L03.3

ICD-10 Finland

Cellulitis of trunk

7.2

9.5

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.2

9.5

431

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

9.5

215

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.4

9.4

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

9.4

681

5615

R11

ICD-10 Finland

Nausea and vomiting

2.2

9.4

471

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.0

9.4

187

N06AX18

ATC

reboxetine; oral

5.9

9.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.4

9.4

133

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

9.3

266

1792

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

9.3

147

828

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

9.3

156

898

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

3.3

9.3

139

-1

NOMESCO Finland

1.5

9.3

383

2814

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

9.3

118

ACC51

NOMESCO Finland

Release of median nerve

2.1

9.3

101

493

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.6

9.3

113

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

9.3

112

572

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

9.3

297

2062

C07AB03

ATC

atenolol; systemic

2.3

9.2

358

M01AX05

ATC

glucosamine; oral

1.6

9.2

242

1594

R31

ICD-10 Finland

Unspecified haematuria

2.0

9.2

118

617

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.1

9.2

168

A03

ICPC

Fever

1.8

9.2

176

1060

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.1

9.2

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

9.2

348

J01FA09

ATC

clarithromycin; systemic

1.5

9.2

373

2736

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.4

9.1

352

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.2

9.1

147

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.6

9.1

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

9.1

158

923

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.4

9.1

-45

ICPC

Observ/health educat/advice/diet

3.2

9.1

142

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

15.7

9.0

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

15.7

9.0

L86

ICPC

Back syndrome with radiating pain

2.4

9.0

324

GD1UN

NOMESCO Finland

Lung circulation SPECT

9.1

9.0

JKA20

NOMESCO Finland

Cholecystectomy

3.2

9.0

143

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

9.0

108

551

-31

ICPC

Medical examin/health eval partial

2.2

9.0

425

R03BA08

ATC

ciclesonide; inhalant

2.1

9.0

104

524

TFP20

NOMESCO Finland

Cardiodefibrillation

2.2

9.0

451

NG1DA

NOMESCO Finland

X-ray of knees

3.8

9.0

SPAT1138

SPAT

Guidance concerning bowel function

5.3

8.9

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

8.9

291

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

8.9

628

5134

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

8.9

589

4758

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

8.9

181

1110

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

8.9

373

F32

ICD-10 Finland

Depressive episode

2.5

8.9

274

C09CA03

ATC

valsartan; oral

2.0

8.9

111

574

N06AX05

ATC

trazodone; oral

3.2

8.9

139

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.9

8.9

184

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

8.0

8.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

8.8

251

1687

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.3

8.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.8

147

847

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

8.8

375

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

8.8

322

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.5

8.8

113

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.2

8.8

370

Z28

ICPC

Limited function/disability (Z)

9.5

8.8

SPAT1054

SPAT

Examination of peripheral nervous system

4.1

8.8

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.7

8.8

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

8.7

288

M01AH02

ATC

rofecoxib; oral

1.8

8.7

168

1011

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.8

8.7

203

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.7

8.7

308

4110

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.8

8.7

SPAT1325

SPAT

Vaccination

1.5

8.7

398

2989

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

4.4

8.6

-1

SPAT

3.0

8.6

159

D12

ICPC

Constipation

3.0

8.6

159

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.7

8.6

E000002

ATC

1.9

8.5

130

725

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

8.5

360

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.6

8.5

-50

ICPC

Medication/prescr/renewal

2.6

8.5

232

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.4

8.5

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

4.2

8.5

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.7

8.5

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.4

8.4

886

K59.0

ICD-10 Finland

Constipation

2.4

8.4

310

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

8.4

150

882

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

8.4

225

1492

C09CA06

ATC

candesartan; oral

1.6

8.4

256

1753

C09AA03

ATC

lisinopril; oral

2.5

8.3

265

R4180

NOMESCO Finland

Podiatric therapy

5.1

8.3

S06.0

ICD-10 Finland

Concussion

1.9

8.3

117

633

QCJ05

NOMESCO Finland

Correction of loose or redundant skin of upper limb

+∞

8.3

SPAT1060

SPAT

Administration of oxygen

8.6

8.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.9

8.3

168

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

10.8

8.3

S19

ICPC

Skin injury other

2.6

8.3

223

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

8.3

151

897

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

8.3

215

C07BB07

ATC

bisoprolol and thiazides; systemic

2.6

8.3

230

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.3

8.2

SPAT1284

SPAT

Extensive health certificate

3.1

8.2

142

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

14.6

8.2

N95.0

ICD-10 Finland

Postmenopausal bleeding

2.0

8.2

104

542

P28

ICPC

Limited function/disability (P)

6.5

8.2

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.1

8.2

EBA30

NOMESCO Finland

Excision of root of tooth

2.3

8.1

334

R04.2

ICD-10 Finland

Haemoptysis

2.9

8.1

165

R52.2

ICD-10 Finland

Other chronic pain

2.9

8.1

172

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.1

8.1

138

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

33.5

8.1

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.5

8.1

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

8.1

444

D05AX52

ATC

calcipotriol, combinations; topical

2.2

8.1

349

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

9.0

8.0

D07AB08

ATC

desonide; topical

1.8

8.0

126

712

R32

ICD-10 Finland

Unspecified urinary incontinence

3.1

8.0

139

N05AB01

ATC

dixyrazine; systemic

4.6

8.0

N04BC05

ATC

pramipexole; oral

2.1

8.0

461

N07BA03

ATC

varenicline; oral

2.3

8.0

309

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

5.9

8.0

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.6

8.0

232

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.4

8.0

659

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.6

8.0

233

P01

ICPC

Feeling anxious/nervous/tense

2.0

8.0

504

I49.5

ICD-10 Finland

Sick sinus syndrome

3.0

8.0

151

R01AD09

ATC

mometasone; nasal

1.4

7.9

531

4270

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

7.9

216

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

7.9

118

654

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.7

7.9

199

-69

ICPC

Other reason for encounter NEC

2.6

7.9

217

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.1

7.9

135

R99

ICPC

Respiratory disease other

4.0

7.9

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

5.2

7.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.1

7.9

GBB00

NOMESCO Finland

Tracheostomy

5.7

7.8

SPAT1324

SPAT

Screening procedure

0.5

7.8

1321

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.7

7.8

XQ800

NOMESCO Finland

Prick test

2.0

7.8

475

QDA10

NOMESCO Finland

Incision of skin of lower limb

7.0

7.8

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.9

7.8

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.8

7.8

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

7.8

131

L90

ICPC

Osteoarthrosis of knee

2.2

7.8

389

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

7.7

275

1947

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

7.7

126

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.5

7.7

N62

ICD-10 Finland

Hypertrophy of breast

2.6

7.7

224

J42

ICD-10 Finland

Unspecified chronic bronchitis

6.0

7.7

N05AE04

ATC

ziprasidone; systemic

7.5

7.7

30180

ICD-8 Finland

Personality disorders, Immatura

7.5

7.7

R03DC01

ATC

zafirlukast; oral

3.9

7.7

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

7.7

208

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

7.6

145

870

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.2

7.6

338

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

18.5

7.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

7.6

234

1603

QBJ00

NOMESCO Finland

Liposuction in trunk

8.1

7.6

I26

ICD-10 Finland

Pulmonary embolism

5.0

7.6

XF404

NOMESCO Finland

Ambulatory ECG

1.9

7.6

113

627

K81.9

ICD-10 Finland

Cholecystitis, unspecified

5.2

7.6

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

5.2

7.6

A29

ICPC

General symptom/complaint other

1.8

7.6

131

765

N06AA10

ATC

nortriptyline; systemic

3.4

7.5

101

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.5

7.5

L29

ICPC

Musculoskeletal sympt/complt other

2.0

7.5

439

A41.8

ICD-10 Finland

Other specified sepsis

4.2

7.5

N06AA06

ATC

trimipramine; systemic

3.1

7.5

129

M01AB05

ATC

diclofenac; systemic, rectal

1.4

7.5

839

7347

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

7.5

253

1770

M02AA10

ATC

ketoprofen; topical

1.6

7.4

198

1308

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.3

7.4

290

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

7.4

188

B35.3

ICD-10 Finland

Tinea pedis

2.5

7.4

213

R33

ICD-10 Finland

Retention of urine

2.0

7.4

462

Z03

ICPC

Housing/neighbourhood problem

6.5

7.4

N06AA22

ATC

6.5

7.4

S20

ICPC

Corn/callosity

3.3

7.4

108

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.1

7.4

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.0

7.4

136

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

13.4

7.4

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

13.4

7.4

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.9

7.4

R03CC02

ATC

salbutamol; systemic

2.8

7.4

159

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.7

7.3

176

D01BA02

ATC

terbinafine; oral; topical

1.5

7.3

308

2259

R52.9

ICD-10 Finland

Pain, unspecified

1.9

7.3

105

573

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.3

7.3

298

A01AB09

ATC

miconazole; local oral

1.9

7.3

107

589

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

7.3

104

X58

ICD-10 Finland

Exposure to other specified factors

1.7

7.3

155

963

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.2

7.3

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

7.2

321

M54.3

ICD-10 Finland

Sciatica

2.1

7.2

369

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

15.8

7.2

G72.8

ICD-10 Finland

Other specified myopathies

4.3

7.2

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.4

7.2

241

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

7.2

325

N03AF02

ATC

oxcarbazepine; oral

2.9

7.2

149

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

7.2

438

WX204

NOMESCO Finland

Axillary plexus blockaced

2.8

7.2

156

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.8

7.2

156

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.7

7.2

173

A99

ICPC

Disease/condition unspecnature/site

2.0

7.1

498

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.4

7.1

SPAT1058

SPAT

PEF monitoring instruction

1.9

7.1

100

543

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

3.0

7.1

134

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

4.2

7.1

C10AB05

ATC

fenofibrate; oral

3.5

7.1

SPAT1335

SPAT

Plan for further care, organisation of further care

5.1

7.1

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

7.1

479

3834

L08

ICPC

Shoulder symptom/complaint

1.5

7.1

223

1533

R05DA01

ATC

ethylmorphine; oral

1.9

7.1

102

560

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

7.1

210

1421

30041

ICD-8 Finland

Neuroses, Depressiva

4.6

7.1

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

7.1

516

N03AF01

ATC

carbamazepine; oral, rectal

2.2

7.1

331

J01EA01

ATC

trimethoprim; systemic

1.5

7.0

280

2025

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.2

7.0

107

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

10.1

7.0

F50.9

ICD-10 Finland

Eating disorder, unspecified

10.1

7.0

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

7.0

230

B37.2

ICD-10 Finland

Candidiasis of skin and nail

7.0

B86

ICD-10 Finland

Scabies

4.0

7.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

7.0

S12

ICPC

Insect bite/sting

0.3

6.9

543

SPAT1244

SPAT

Occupational therapy

5.9

6.9

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

13.8

6.9

40199

ICD-8 Finland

Essential benign hypertension

3.8

6.9

R01AD08

ATC

fluticasone; nasal

1.4

6.9

330

2482

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.1

6.8

115

J37.0

ICD-10 Finland

Chronic laryngitis

2.7

6.8

166

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

8.3

6.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

6.8

191

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

6.8

126

749

WX213

NOMESCO Finland

Lower leg blockade

6.7

6.8

L28.1

ICD-10 Finland

Prurigo nodularis

6.7

6.8

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.2

6.8

323

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

6.8

257

C09DA06

ATC

candesartan and diuretics; oral

1.9

6.8

484

V03AA01

ATC

3.4

6.8

A10BD08

ATC

metformin and vildagliptin; systemic

5.7

6.8

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

6.8

105

C08CA10

ATC

nilvadipine; oral

3.4

6.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

6.7

111

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.6

6.7

M01AH05

ATC

etoricoxib; oral

1.4

6.7

725

6251

-64

ICPC

Encounter/prob initiated by provider

4.0

6.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

3.8

6.7

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.2

6.7

106

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

22.6

6.7

W19

ICD-10 Finland

Unspecified fall

1.8

6.7

109

623

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.5

6.7

195

N06AG02

ATC

moclobemide; oral

2.2

6.6

279

J94.8

ICD-10 Finland

Other specified pleural conditions

3.8

6.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

6.6

180

1194

M25.5

ICD-10 Finland

Pain in joint

1.4

6.6

330

2499

J01DC02

ATC

cefuroxime; systemic

2.1

6.6

363

R10.0

ICD-10 Finland

Acute abdomen

2.6

6.6

182

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

10.1

6.5

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

6.9

6.5

KGH10

NOMESCO Finland

Operation for phimosis

3.0

6.5

114

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

6.5

159

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.0

6.5

D07AD01

ATC

clobetasol; topical

1.6

6.5

179

1192

Z71.8

ICD-10 Finland

Other specified counselling

1.5

6.5

252

1813

B01AF01

ATC

rivaroxaban; oral

1.7

6.5

139

865

K28

ICPC

Limited function/disability (K)

3.2

6.4

F61.1

ICD-10 Finland

Disturbing personality change

70.2

6.4

RK310

NOMESCO Finland

70.2

6.4

OAB48

SPAT

0.3

6.4

476

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

7.4

6.4

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.7

6.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.7

6.4

Z01

ICPC

Poverty/financial problem

14.4

6.4

R40.0

ICD-10 Finland

Somnolence

14.4

6.4

J01CA08

ATC

pivmecillinam; oral

1.4

6.4

430

3429

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.9

6.4

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.0

6.4

110

SPAT1081

SPAT

Cardiorespiratory global assessment

2.1

6.4

338

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

4.9

6.4

F32.8

ICD-10 Finland

Other depressive episodes

4.4

6.4

A02BA02

ATC

ranitidine; systemic

1.5

6.4

224

1578

M46.4

ICD-10 Finland

Discitis, unspecified

8.2

6.3

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.8

6.3

101

575

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

6.3

144

912

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.5

6.3

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.7

6.3

146

F50.8

ICD-10 Finland

Other eating disorders

11.1

6.3

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

11.1

6.3

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

6.3

104

597

WX002

NOMESCO Finland

Sedation and analgesia

1.5

6.3

230

1631

K11.70

ICD-10 Finland

Hypoptyalism

9.3

6.3

RS221

NOMESCO Finland

3.7

6.3

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.3

6.3

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.8

6.3

140

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.3

6.3

251

E65

ICD-10 Finland

Localized adiposity

18.1

6.3

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

6.3

174

JDF21

NOMESCO Finland

Laparoscopic gastric banding

+∞

6.3

-54

ICPC

Repair/fix-suture/cast/prosth device

2.9

6.2

127

L30.3

ICD-10 Finland

Infective dermatitis

2.5

6.2

183

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.3

6.2

J04AB02

ATC

rifampicin; systemic

4.3

6.2

C07FB02

ATC

metoprolol and felodipine; systemic

2.7

6.2

141

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

7.1

6.2

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

7.1

6.2

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

6.2

143

907

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.1

6.2

SPAT1146

SPAT

Puncture of abscess or incision of skin

3.3

6.2

D02AE01

ATC

carbamide; topical

2.0

6.2

402

Z29

ICPC

Social problem NOS

3.9

6.2

S75

ICPC

Moniliasis/candidiasis skin

6.3

6.2

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

6.2

378

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

5.8

6.1

C09BA03

ATC

lisinopril and diuretics; oral

2.8

6.1

136

XKC03

NOMESCO Finland

Water cystometry

2.7

6.1

153

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.2

6.1

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

7.7

6.1

A08AA01

ATC

phentermine; oral

7.7

6.1

C07BB02

ATC

metoprolol and thiazides; systemic

4.0

6.1

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019060) Gas panel - Arterial blood

513

799

9.37

307.65

5.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

411

677

8.06

253.17

6.8

3.4

4.4

1.6

mmol/l

22.37

356

518

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

414

709

7.76

245.61

7.2

3.5

6.1

5.1

kpa

35.64

401

669

(3009343) pH of Capillary blood

412

702

7.79

245.57

7.1

3.5

7.4

1.32

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

573

1393

6.13

237.82

9.7

8.0

6.3

5.1

kpa

61.89

558

1334

(3027801) Oxygen [Partial pressure] in Arterial blood

573

1393

6.13

237.82

9.7

8.0

8.8

12.3

kpa

73.38

553

1335

(3003396) Base excess in Arterial blood by calculation

570

1390

6.09

235.50

9.7

8.0

3.8

1.0

mmol/l

35.35

513

1094

(3016502) Oxygen saturation in Arterial blood

497

1259

5.47

192.26

9.3

8.4

91.5

95.6

25.30

480

1211

(1616796) Gas panel - Central venous blood

213

229

10.72

183.08

7.7

2.9

—

(3023368) Bacteria identified in Blood by Culture

806

3224

4.36

169.51

7.2

4.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

222

280

9.17

168.65

5.7

2.8

28.4

25.0

mmol/l

11.47

207

249

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

823

3380

4.30

165.89

4.8

2.9

1649.4

1246.2

ng/l

1.09

703

2898

(3013290) Carbon dioxide [Partial pressure] in Blood

200

234

9.75

160.92

9.7

3.3

5.7

5.0

kpa

14.77

195

229

(3027315) Oxygen [Partial pressure] in Blood

200

234

9.75

160.92

9.7

3.3

8.2

8.6

kpa

1.37

195

229

(3012501) Base excess in Blood by calculation

199

234

9.69

159.47

9.7

3.3

4.6

2.4

mmol/l

8.63

163

151

(3010421) pH of Blood

218

288

8.73

159.24

9.5

3.1

7.4

1.35

194

229

(3003458) Phosphate [Moles/volume] in Serum or Plasma

495

1531

4.38

144.47

5.8

5.7

1.1

1.0

mmol/l

4.40

453

1409

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

301

626

5.80

142.16

10.1

10.3

26.7

24.3

mmol/l

17.91

281

594

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

304

674

5.44

133.25

10.9

7.3

28.1

24.8

mmol/l

20.43

299

669

(3022313) Gas panel - Capillary blood

262

510

6.04

132.37

7.9

3.6

—

(3021901) Oxygen saturation in Capillary blood

169

204

9.24

132.13

4.9

2.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

538

1914

3.87

126.68

3.1

3.5

0.8

mmol/l

0.14

490

1788

(3020682) Albumin/Creatinine [Ratio] in Urine

802

3730

3.56

124.11

4.8

3.8

12.7

7.7

mg/mmol

1.91

510

2312

(40767503) Oxygen content in Capillary blood by calculation

172

230

8.35

123.58

4.9

2.4

16.2

16.5

0.30

112

122

(3012516) Albumin [Mass/volume] in Urine

765

3528

3.46

118.54

3.5

3.2

471.1

357.6

mg/l

0.26

497

2203

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

521

1924

3.66

114.24

2.8

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

403

1255

4.06

113.50

6.1

3.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

957

5154

3.50

113.18

5.7

4.8

32.9

35.7

g/l

42.77

895

4798

(3009508) Creatinine [Moles/volume] in Urine

779

3717

3.35

112.52

3.5

3.1

7.3

7.5

mmol/l

0.68

607

3142

(3032080) INR in Blood by Coagulation assay

908

4857

3.31

106.08

15.6

9.4

1.3

1.2

inr

0.52

386

1395

(3007853) Bacteria identified in Skin by Aerobe culture

411

1361

3.81

105.14

2.4

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

375

1175

3.95

103.83

10.9

8.9

132.3

121.3

g/l

15.35

370

1126

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

644

2878

3.22

101.38

3.0

2.1

4.3

3.0

mg/l

15.51

549

2454

(40761536) Microorganisms panel - Urine sediment

333

985

4.09

99.68

5.6

3.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

212

444

5.42

97.74

8.6

3.8

26.6

24.8

mmol/l

9.38

204

414

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

431

1545

3.54

96.87

3.2

2.5

17.2

23.5

17.29

356

1301

(3006184) Hemoglobin [Mass/volume] in Capillary blood

157

248

6.97

96.76

3.8

2.1

134.5

131.2

g/l

0.64

129

181

(3019309) Folate [Moles/volume] in Red Blood Cells

521

2117

3.27

95.35

2.6

1.7

1407.5

1177.7

nmol/l

4.75

384

1601

(3004789) Transferrin [Mass/volume] in Serum or Plasma

446

1650

3.45

95.16

3.1

2.4

2.5

2.3

g/l

7.27

391

1533

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

572

2483

3.15

93.12

2.5

1.6

441.2

41411622.8

pmol/l

2.81

456

2055

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

850

4603

3.03

92.82

6.4

3.5

38.2

48.9

ng/l

0.62

678

3179

(3008152) Bicarbonate [Moles/volume] in Arterial blood

281

772

4.27

92.59

11.5

7.6

28.5

24.5

mmol/l

32.25

271

719

(3020891) Body temperature

214

473

5.13

92.57

7.9

4.4

—

(3002032) Base excess in Venous blood by calculation

335

1061

3.80

90.25

5.2

3.5

4.9

1.8

mmol/l

20.90

297

855

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

944

5483

3.05

89.48

11.3

6.0

1.2

mmol/l

13.08

854

4990

(3021447) Carbon dioxide [Partial pressure] in Venous blood

334

1068

3.76

88.59

5.2

3.5

7.2

5.8

kpa

34.15

319

1037

(3022948) Iron [Moles/volume] in Serum or Plasma

458

1798

3.26

87.76

3.2

2.4

10.2

13.4

umol/l

18.76

406

1654

(42870588) Differential panel, method unspecified - Blood

776

4105

2.90

86.60

6.5

5.9

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

209

483

4.88

85.51

2.5

2.0

1.6

ug/l

0.04

187

429

(3026008) Bacteria identified in Urine by Culture

684

3419

2.89

84.37

4.5

3.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

310

972

3.78

84.33

5.5

3.4

1.2

mmol/l

7.22

258

841

(3013826) Glucose [Moles/volume] in Serum or Plasma

1092

7086

3.16

80.85

10.9

4.7

7.5

6.7

mmol/l

17.58

1040

6670

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

981

6020

2.93

80.26

11.0

6.7

1.2

mmol/l

18.33

740

5112

(3020779) Urea [Moles/volume] in Serum or Plasma

320

1063

3.58

79.45

7.6

7.7

12.9

9.2

mmol/l

11.47

309

1016

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

570

2679

2.85

77.60

2.0

1.8

1.1

1.2

mg/l

0.14

457

2050

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

369

1360

3.29

77.44

2.6

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

366

1349

3.29

76.73

2.6

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

634

3210

2.73

73.91

3.3

2.6

2081.5

5809.5

umol/l

2.41

536

2801

(3017569) Oxygen content in Arterial blood

13.32

72.96

2.5

2.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

308

1061

3.41

71.67

11.0

7.2

1.5

1.4

mmol/l

0.95

294

1025

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

234

682

3.90

70.01

2.0

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

992

6377

2.74

69.61

6.4

6.5

11.3

11.6

umol/l

0.23

926

6074

(3042936) Bacteria identified in Isolate by Culture

407

1696

2.94

68.02

2.8

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

267

872

3.52

67.28

4.9

2.6

5.0

4.5

kpa

2.08

252

845

(3019069) Monocytes/100 leukocytes in Blood

908

5693

2.58

65.29

7.5

6.3

8.4

8.7

2.81

866

5336

(3006504) Eosinophils/100 leukocytes in Blood

904

5673

2.56

64.60

7.3

6.0

2.5

2.9

4.59

857

5295

(3000991) Gas panel - Venous blood

284

990

3.32

64.33

11.6

8.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

686

3804

2.52

63.85

3.3

2.5

46.5

58.0

u/l

3.38

619

3511

(3001122) Ferritin [Mass/volume] in Serum or Plasma

816

4902

2.51

63.79

4.4

2.7

120.5

137.6

ug/l

1.56

727

4533

(3006315) Basophils [#/volume] in Blood

946

6086

2.58

63.76

6.9

5.8

0.0

e9/l

0.03

846

5285

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

308

1134

3.18

63.64

2.5

2.2

0.2

g/l

5.85

280

1068

(3001604) Monocytes [#/volume] in Blood

943

6066

2.57

63.43

6.8

5.8

0.7

0.6

e9/l

16.70

848

5258

(3013115) Eosinophils [#/volume] in Blood

965

6285

2.59

63.05

7.5

6.1

0.2

e9/l

0.79

863

5542

(3019977) pH of Arterial blood

11.47

62.72

2.5

3.5

7.4

0.48

(3022096) Basophils/100 leukocytes in Blood

882

5526

2.51

62.38

7.4

6.1

0.6

0.7

9.38

838

5171

(3002030) Lymphocytes/100 leukocytes in Blood

914

5829

2.52

62.07

7.4

6.1

22.9

27.9

38.63

868

5449

(3019198) Lymphocytes [#/volume] in Blood

953

6215

2.54

61.35

6.9

5.8

1.8

2.0

e9/l

1.69

862

5493

(3026782) Osmolality of Urine

484

2312

2.64

61.18

3.4

2.7

517.5

550.3

mosm/kgh2o

2.60

422

1982

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

250

832

3.42

60.80

1.9

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

190

548

3.84

57.23

4.9

3.7

26.5

24.0

mmol/l

10.67

169

503

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

131

286

4.93

56.76

1.8

1.7

—

(3018418) pH of Serum or Plasma

642

3606

2.40

56.16

5.6

3.9

7.4

0.44

240

669

(3018010) Neutrophils/100 leukocytes in Blood

888

5747

2.40

55.93

7.1

5.9

62.6

57.1

35.86

847

5395

(3036481) Cortisol [Moles/volume] in Serum or Plasma

283

1065

3.06

55.75

2.2

2.1

313.7

375.9

nmol/l

5.12

260

989

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

142

338

4.55

55.34

2.2

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

278

4.91

54.83

1.8

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

489

2488

2.45

52.74

3.5

2.5

8.1

5.5

e6/l

2.93

436

2213

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

775

4887

2.25

49.70

3.3

2.2

69.6

78.4

nmol/l

16.42

694

4390

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1230

9490

2.90

49.39

10.2

7.6

87.9

77.8

u/l

5.92

1167

8949

(3014576) Chloride [Moles/volume] in Serum or Plasma

340

1498

2.66

49.27

11.6

7.1

101.8

104.4

mmol/l

15.51

323

1461

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

208

5.25

48.74

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1073

7784

2.44

48.65

7.3

4.3

235.8

2258.7

e6/l

1.55

110

(3029937) Albumin [Presence] in Urine by Test strip

562

3137

2.29

48.11

5.6

3.8

0.0

estimate

0.18

278

1047

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

7.34

45.17

1.9

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

670

4111

2.17

44.45

3.1

3.6

2.3

2.4

mmol/l

4.00

582

3623

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

138

378

3.93

44.43

3.1

3.3

0.4

u/ml

0.62

213

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

754

4847

2.15

44.29

2.6

1.9

90.2

95.6

pmol/l

2.44

459

2521

(3013650) Neutrophils [#/volume] in Blood by Automated count

990

7097

2.23

43.66

10.5

9.3

5.2

4.0

e9/l

34.74

891

6235

(3013512) EKG study

595

3520

2.17

42.98

5.1

3.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1097

8230

2.35

42.89

6.2

4.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

497

2747

2.23

42.51

1.9

1.5

19.5

20.9

nmol/l

1.31

427

2342

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

6.12

42.42

1.9

1.8

—

(3021589) Normoblasts [#/volume] in Blood

805

5372

2.11

42.09

18.5

9.2

0.0

e9/l

0.32

698

4410

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

173

5.28

41.83

1.8

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

4.89

41.57

1.7

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

167

544

3.34

41.36

5.1

3.1

28.7

25.2

mmol/l

12.49

156

527

(3040151) Glucose [Moles/volume] in Capillary blood

118

6.27

41.23

6.7

8.0

7.4

7.3

mmol/l

0.15

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

177

5.16

40.76

1.7

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

643

3978

2.10

40.75

3.1

3.2

31.7

32.6

u/l

0.29

593

3796

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

118

307

4.09

40.73

1.4

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

595

3587

2.11

40.28

4.3

3.1

74.0

77.7

e6/l

0.04

507

2753

(3002179) Metamyelocytes/100 leukocytes in Blood

230

915

2.80

40.09

3.7

4.1

0.7

0.6

0.33

216

(40760892) CBC W Ordered Manual Differential panel - Blood

481

2676

2.19

40.03

5.6

4.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

292

1314

2.53

39.72

2.3

2.7

2.1

1.8

5.15

238

1178

(3021440) Promyelocytes/100 leukocytes in Blood

233

949

2.73

38.75

4.4

4.3

0.0

0.1

1.93

270

(3025159) Blasts/100 leukocytes in Blood

224

896

2.77

38.56

4.5

4.4

0.0

0.5

0.66

229

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

158

5.23

37.72

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

5.17

37.66

1.7

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

239

1006

2.65

37.15

4.4

4.2

1.1

1.0

0.18

295

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

205

4.56

35.94

3.6

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

532

3181

2.06

35.85

5.1

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

842

5922

2.00

35.71

5.1

3.5

0.0

estimate

0.33

274

1046

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

231

976

2.62

35.54

4.5

3.0

191.8

200.6

ng/l

0.13

216

888

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.69

35.37

1.8

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

832

5843

1.99

35.25

5.1

3.5

0.0

estimate

0.00

307

1071

(3030467) Casts [#/volume] in Urine by Automated count

544

3302

2.03

34.98

4.2

3.0

0.9

0.5

e6/l

2.83

461

2493

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

149

501

3.20

34.88

6.6

3.3

54.6

49.2

1.63

143

496

(36304419) Bacteria [Presence] in Urine

533

3229

2.03

34.31

4.1

3.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

830

5866

1.96

34.04

6.2

4.8

0.0

estimate

0.50

305

1080

(3004119) Hemoglobin [Mass/volume] in Venous blood

186

722

2.81

33.70

4.6

3.0

135.0

128.6

g/l

2.80

176

704

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.97

33.67

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

7.42

33.62

1.8

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

582

3659

1.98

33.54

2.8

2.1

163.0

219.2

u/l

1.40

540

3463

(3023183) Ammonium ion [Moles/volume] in Plasma

101

273

3.90

32.99

3.2

3.1

35.6

34.5

umol/l

0.18

238

(3018095) Leukocytes [#/volume] in Urine

637

4162

1.94

32.51

5.0

3.6

109.1

101.7

e6/l

0.07

523

2965

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

174

670

2.81

31.95

13.8

11.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

179

702

2.77

31.74

2.6

1.6

—

(4010399)

204

859

2.60

31.41

1.7

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

120

379

3.36

31.04

7.9

3.9

4.0

3.9

mmol/l

1.52

108

357

(3023520) Reticulocytes [#/volume] in Blood

221

987

2.46

29.98

2.5

2.8

84.8

71.5

e9/l

5.49

167

763

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

138

487

3.03

29.64

7.0

6.5

2.4

1.6

4.10

131

450

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

124

413

3.19

29.39

2.2

2.4

437.5

482.9

ug/l

0.11

117

385

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

274

3.68

28.97

2.7

2.5

220.4

111.1

ug/min

0.55

167

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1131

9278

1.98

25.57

5.1

4.0

14.8

pmol/l

0.24

1030

8450

(3007930) Methemoglobin/Hemoglobin.total in Blood

130

483

2.86

25.38

7.6

6.5

0.8

0.9

1.83

124

447

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

651

4535

1.79

25.14

5.6

3.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

198

910

2.36

24.98

4.3

3.7

121.0

88.9

ng/l

3.35

161

804

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1315

11460

2.51

24.89

10.3

5.4

46.8

39.5

mmol/mol

70.15

1221

10627

(3003338) MCHC [Mass/volume]

846

10373

0.56

24.59

41.8

18.0

322.7

332.6

g/l

92.50

836

10302

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1016

8096

1.84

24.52

4.7

3.1

61.5

49.8

u/l

4.54

932

7559

(3022217) INR in Platelet poor plasma by Coagulation assay

282

1509

2.08

24.38

31.5

24.1

1.5

1.3

inr

1.05

212

(3000494) Fungus identified in Specimen by Culture

273

1464

2.06

23.38

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

239

3.53

23.25

1.8

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

239

3.53

23.25

1.8

1.3

—

(3015736) pH of Urine

639

4531

1.73

22.40

4.0

3.3

—

5.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

104

366

2.98

22.37

2.1

3.9

1.2

1.7

ratio

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

370

2.95

21.94

2.1

4.0

60.4

66.2

mg/l

0.13

299

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

372

2.93

21.73

2.1

4.0

57.6

87.5

mg/l

0.36

302

(3047181) Lactate [Moles/volume] in Blood

107

389

2.89

21.71

11.1

7.6

1.4

1.3

mmol/l

0.32

336

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

256

1376

2.04

21.67

2.4

4.7

236.9

246.7

u/l

0.61

228

1303

(3044242) Glucose [Moles/volume] in Arterial blood

6.00

20.95

2.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

201

1001

2.17

20.75

1.8

2.9

66.2

66.6

g/l

0.31

180

916

(3013707) Erythrocyte sedimentation rate by Westergren method

1090

9066

1.80

20.59

5.4

4.0

22.8

11.7

mm/h

47.66

998

8378

(3009466) Valproate [Moles/volume] in Serum or Plasma

175

3.78

20.55

6.4

5.0

379.4

365.7

umol/l

0.31

154

(40760888) Immunoglobulin light chains.free panel - Serum

283

3.09

19.49

2.0

4.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

163

3.73

18.68

4.9

7.5

11.7

11.4

mg/l

0.15

154

(3027456) Digoxin [Moles/volume] in Serum or Plasma

219

3.31

18.35

3.7

3.1

0.9

0.8

nmol/l

0.31

170

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

114

467

2.56

18.33

3.2

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

424

2.62

17.89

3.0

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

6.23

17.69

3.4

4.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

315

2.84

17.21

2.7

2.9

2.1

1.5

mg/l

4.42

291

(3004588) Protein electrophoresis panel - Serum or Plasma

169

848

2.12

16.99

1.8

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

153

739

2.20

16.94

1.4

1.3

198.0

193.2

u/ml

0.05

144

678

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1256

11135

1.93

16.60

6.3

4.7

2.0

mu/l

0.18

1156

10179

(3023419) Bacteria identified in Sputum by Culture

164

3.51

16.29

3.3

2.6

—

(3025941) Bacteria identified in Stool by Culture

133

619

2.26

16.10

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.25

15.84

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.25

15.84

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1112

0.23

15.38

2.0

1.8

—

(3004451) EKG impression Narrative

5.56

15.28

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

119

542

2.30

15.16

1.3

1.9

1.8

1.5

g/l

2.03

474

(3004809) Band form neutrophils/100 leukocytes in Blood

189

3.21

14.92

1.8

4.1

0.8

1.5

1.15

158

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

8.10

14.91

4.5

1.6

5.5

8.1

mmol/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

341

2232

1.69

14.83

3.2

3.0

2.5

2.4

mmol/l

6.17

299

1983

(3005719) IgG [Mass/volume] in Serum or Plasma

173

923

1.99

14.67

2.7

2.8

10.7

10.5

g/l

0.19

153

843

(3024891) Influenza virus A+B Ag [Presence] in Specimen

309

2.68

14.49

1.5

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

143

718

2.10

14.30

2.0

1.8

1.2

1.4

g/l

0.40

133

658

(3024928) Oxygen saturation in Venous blood

265

2.81

14.30

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

238

1421

1.81

14.27

2.3

1.8

1.5

0.28

199

1232

(4146454)

113

3.80

13.85

3.3

2.6

—

(40758558) Short blood count panel - Blood

436

3090

1.59

13.61

7.1

6.9

—

(3018572) Chloride [Moles/volume] in Blood

285

2.68

13.49

10.5

8.9

103.0

105.4

mmol/l

4.33

251

(3039000) Anion gap in Blood

285

2.68

13.49

10.5

8.9

9.9

11.3

mmol/l

2.45

251

(21494755) Public health laboratory ask at order entry panel

1108

0.28

13.21

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

246

2.76

12.82

1.8

1.6

1.4

0.8

nmol/l

2.58

208

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

410

2.35

12.77

1.9

1.5

102.2

137.1

titre

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

183

1044

1.86

12.65

3.1

2.4

4.8

7.6

ug/l

2.33

146

933

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

346

2357

1.61

12.61

6.0

3.6

207.5

382.0

ng/l

1.20

301

1837

(3004775) Volume in Urine collected for unspecified duration

4.00

12.49

1.9

2.3

795.8

662.2

0.61

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1325

12187

1.96

12.42

37.4

13.8

27.0

24.1

mg/l

2.85

1260

9561

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

3.65

12.20

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

3.65

12.20

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

3.65

12.20

1.5

1.7

—

(3016750) Collection duration of Urine

4.42

12.19

2.1

2.2

480.5

500.7

min

0.54

(3045716) Anion gap in Serum or Plasma

4.53

12.16

2.7

8.2

9.5

mmol/l

0.64

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

224

1380

1.74

11.94

2.5

2.7

7.1

8.4

umol/l

0.38

171

1214

(3021788) Differential panel - Synovial fluid

223

2.76

11.73

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

292

2.50

11.36

1.1

1.2

—

930.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.95

11.34

4.2

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.95

11.34

4.2

2.9

—

(3042631) Mycobacterium sp identified in Specimen

172

2.97

11.26

3.3

2.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

285

1899

1.62

11.24

2.6

2.1

31.1

29.7

3.06

277

1839

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

206

2.79

11.18

1.2

1.3

25.5

31.5

u/l

0.25

177

(46235355) HIV 1 and 2 tests - Meaningful Use set

258

1682

1.65

11.09

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

264

1732

1.64

11.06

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

3.32

10.86

1.7

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

104

3.52

10.75

1.4

1.3

7.8

7.0

g/l

0.26

(3028192) IgG subclass 2 [Mass/volume] in Serum

104

3.52

10.75

1.4

1.3

2.2

2.9

g/l

0.79

(3024139) IgG subclass 3 [Mass/volume] in Serum

104

3.52

10.75

1.4

1.3

0.3

0.4

g/l

0.41

(3037522) Nuclear Ab [Titer] in Serum

244

1583

1.65

10.66

1.3

465.0

524.8

titre

0.29

336

(3027923) C peptide [Moles/volume] in Serum or Plasma

4.18

10.64

1.1

1.4

2.1

1.2

nmol/l

2.79

(3037756) Immunofixation for Serum or Plasma

271

2.50

10.61

1.3

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

346

2.33

10.59

1.3

1.6

0.3

0.2

g/l

0.93

329

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.69

10.55

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

334

2.35

10.54

1.3

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

4.52

10.50

1.3

1.2

143.9

142.6

nmol/l

0.03

(3007566) Smooth muscle Ab [Titer] in Serum

291

2.44

10.48

1.0

1.2

66.0

66.5

titre

—

(4062490)

106

3.46

10.46

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

121

3.28

10.45

1.2

1.1

53.2

55.4

u/l

0.15

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

187

2.79

10.26

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

742

0.23

10.21

1.2

1.4

—

(3011985) Renin [Units/volume] in Plasma

149

3.01

10.21

1.2

1.3

51.0

65.4

mu/l

0.32

134

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

359

2.27

10.15

1.3

1.6

1.3

1.2

g/l

2.16

340

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

3.92

10.15

1.6

1.3

38.2

15.4

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

134

3.12

10.10

1.6

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

360

2.26

10.08

1.6

1.5

277.3

285.2

ug/g

0.12

219

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

156

2.94

10.03

1.7

1.6

75.4

59.4

1.70

101

(44790047)

136

3.07

9.86

1.7

1.6

—

(44790049)

136

3.07

9.86

1.7

1.6

—

(44790048)

136

3.07

9.86

1.7

1.6

—

(44806118)

136

3.07

9.86

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

192

1194

1.70

9.82

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

126

3.15

9.80

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

137

3.05

9.74

1.3

302.1

305.2

pmol/l

0.02

111

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.48

9.56

1.7

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.48

9.56

1.7

1.4

—

(3003181) Sodium [Moles/volume] in Urine

213

2.59

9.45

1.4

1.3

66.5

61.0

mmol/l

0.26

180

(3019550) Sodium [Moles/volume] in Serum or Plasma

1357

12749

1.94

9.45

43.1

15.7

139.7

mmol/l

0.15

1328

12426

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

4.39

9.35

1.7

1.9

2.1

5.8

nmol/l

0.48

(44816559) Phosphatidylethanol [Mass/volume] in Blood

203

2.62

9.30

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

127

711

1.86

9.28

3.0

3.4

4.3

4.5

pmol/l

0.83

107

628

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

258

2.42

9.24

1.7

1.4

—

(3014271) Vancomycin [Susceptibility]

4.31

9.14

3.7

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1358

12788

1.91

8.99

43.1

15.8

4.0

mmol/l

4.89

1329

12449

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

346

2526

1.48

8.83

1.3

1.2

2.3

1.6

u/ml

0.33

120

683

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.05

8.80

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.05

8.80

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.05

8.80

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.05

8.80

1.6

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

197

2.59

8.79

1.3

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

3.98

8.62

1.2

1.1

19.8

27.4

u/l

0.35

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

115

3.09

8.58

1.7

1.4

21.0

31.6

0.88

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

149

2.80

8.43

1.8

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

149

2.80

8.43

1.8

1.5

—

(3020491) Glucose [Moles/volume] in Blood

3.50

8.39

3.4

1.6

7.1

7.0

mmol/l

0.17

(3017354) Segmented neutrophils/100 leukocytes in Blood

117

3.04

8.34

2.0

4.3

65.0

52.8

3.13

(3005988) Vibrio sp identified in Specimen by Organism specific culture

150

2.78

8.33

1.8

1.5

—

(3044889) 12 lead EKG panel

1000

8876

1.40

8.04

5.7

3.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

159

2.69

8.01

1.0

1.1

—

(3000492) Spirometry study

181

1178

1.61

7.71

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

151

2.70

7.68

1.8

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

151

2.70

7.68

1.8

1.5

—

(3017732) Neutrophils [#/volume] in Blood

135

817

1.72

7.60

2.9

3.1

4.9

4.0

e9/l

3.62

101

643

(3018851) Theophylline [Moles/volume] in Serum or Plasma

8.38

7.58

1.4

2.3

44.8

40.8

umol/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.12

7.55

1.6

2.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

420

1.98

7.47

3.6

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

673

5655

1.35

7.34

5.2

4.0

—

(3012565) Volume of 24 hour Urine

3.86

7.26

1.7

2.6

1404.4

2048.1

2.24

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

150

2.64

7.24

1.8

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

201

1361

1.55

7.22

1.7

1.5

—

(3022145) Colonoscopy Study observation

207

1413

1.54

7.17

1.4

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.15

7.15

1.0

1.2

—

u/ml

—

(3033658) Prothrombin time (PT) actual/Normal

399

3096

1.40

7.12

5.3

3.9

84.6

90.3

3.82

385

3014

(40768443) Skin Pathology biopsy report

525

1.84

6.96

1.2

—

(3044941) Cell count panel - Synovial fluid

196

2.39

6.92

1.3

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.37

6.84

1.3

1.6

10.1

8.5

u/l

0.18

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

2.79

6.83

4.3

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.81

6.82

2.5

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

2.46

6.72

1.3

1.6

0.5

0.9

g/l

1.11

128

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.92

6.72

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.92

6.72

1.7

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.97

6.71

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

466

3745

1.36

6.61

2.9

2.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

111

2.83

6.60

1.5

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

2.70

6.60

2.2

4.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

298

2225

1.43

6.56

1.7

1.5

3.0

2.5

g/l

3.81

210

1372

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.58

6.46

1.2

—

(3000012) Reticulocyte production index

3.54

6.45

1.2

1.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

6.15

6.43

1.7

1.6

1.2

mmol/l

0.80

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

423

3370

1.36

6.29

1.8

1.7

1.8

1.4

mmol/l

7.80

300

2830

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

3.15

6.18

7.9

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

128

2.61

6.07

3.2

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

269

0.18

5.93

1.6

—

(3019225) pH of Specimen

173

1184

1.52

5.91

6.3

4.3

—

(3008295) Osmolality of Serum or Plasma

132

2.53

5.72

1.2

1.3

279.1

277.6

mosm/kgh2o

0.11

101

(3012441) Differential panel - Pleural fluid

115

2.64

5.66

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

151

2.42

5.66

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

177

2477

0.68

5.61

2.6

3.0

0.6

0.8

ug/l

1.65

114

1603

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

534

1.73

5.49

1.6

1.9

35.0

39.2

u/l

1.10

467

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

154

2.37

5.43

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.77

5.38

1.8

2.1

—

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.03

5.26

9.1

2.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

305

1.94

5.22

1.3

1.6

319.7

302.8

mu/l

0.20

282

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

145

2.38

5.18

1.3

1.2

—

nmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

197

2.17

5.13

1.5

1.9

8619.2

2660.3

u/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

394

1.82

5.12

2.2

2.8

1.0

1.2

g/l

0.20

351

(3042517) Benzodiazepines panel - Urine

13.40

5.08

5.6

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.43

5.03

1.5

3.7

49.7

130.7

umol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

246

2.03

5.03

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

181

1295

1.45

4.97

1.5

1.6

—

(3037121) Protein [Mass/volume] in Urine

430

1.76

4.88

2.4

3.5

0.2

g/l

1.34

177

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1271

12056

1.42

4.82

6.6

4.5

6.7

5.9

mmol/l

46.56

1132

11017

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1.82

4.81

1.4

2.6

35.7

37.8

g/l

2.16

318

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.61

4.78

1.2

1.1

—

(3024263) Appearance of Synovial fluid

3.18

4.77

1.2

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

1.74

4.70

1.6

2.7

3.4

3.1

g/l

2.32

345

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

267

3391

0.74

4.69

3.6

4.2

21.0

21.4

0.12

1608

(3001019) Free T4 and TSH panel - Serum or Plasma

619

0.44

4.64

1.6

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

254

1.96

4.63

1.3

10.5

10.4

u/l

0.02

207

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

1.73

4.54

1.6

2.8

10.6

10.4

g/l

0.18

370

(40757373) Influenza virus identified in Isolate

4.02

4.44

1.7

1.8

—

(1761868) Lipid panel - Serum or Plasma

529

4517

1.27

4.44

3.7

2.8

—

(40761511) CBC panel - Blood by Automated count

1330

12757

1.49

4.41

34.1

13.0

—

(4015189)

3.74

4.37

3.4

2.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

818

7357

1.26

4.36

3.4

2.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

268

1.90

4.30

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

1.68

4.30

1.6

2.7

8.1

7.2

g/l

4.30

356

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

328

1.80

4.23

1.5

2.7

0.0

g/l

0.00

303

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

300

1.83

4.17

1.3

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

301

1.82

4.13

1.4

1.7

20079.4

14283.1

e6/l

0.50

227

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

331

1.78

4.11

1.5

2.7

0.0

g/l

0.00

304

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.65

4.07

1.4

12.2

13.4

u/l

0.39

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

1.66

4.06

1.6

2.7

4.3

3.7

g/l

2.74

338

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

462

1.66

4.06

1.6

2.7

—

(3048689) Calprotectin [Mass/mass] in Stool

182

1360

1.39

3.93

2.3

2.2

164.4

122.7

ug/g

1.21

140

1094

(3016650) Hepatitis A virus Ab [Presence] in Serum

185

2.03

3.90

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

444

1.65

3.89

1.4

1.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.19

3.89

1.6

1.4

26.7

25.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

2.16

3.88

2.8

2.5

36.3

24.2

mg/l

—

(3035880) pH of Pleural fluid

2.79

3.86

1.2

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

133

2.20

3.81

1.4

5130.7

1626.0

e6/l

0.74

(4198724)

3.55

3.77

1.8

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

2.38

3.75

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method

195

1.97

3.75

3.6

2.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

349

1.72

3.73

1.5

2.7

0.0

g/l

1.09

321

(3020650) Glucose [Presence] in Urine

3.69

3.64

1.8

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

219

1.90

3.61

2.8

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

191

1.96

3.60

1.0

1.1

17.6

124.5

iu/ml

1.25

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

241

1907

1.32

3.58

3.8

2.8

5.2

2.0

e6/l

2.96

140

1023

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

105

2.31

3.53

1.1

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1230

11725

1.31

3.52

30.4

12.7

78.8

80.5

ml/min/173m2

1.47

1080

9708

(3028308) Erythrocytes [#/volume] in Pleural fluid

119

2.21

3.46

1.4

27372.8

86274.6

e6/l

0.53

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

196

1515

1.34

3.42

5.7

4.4

29.0

32.4

5.46

142

1025

(3041354) Potassium [Moles/volume] in Venous blood

140

2.09

3.39

3.1

2.3

4.1

4.0

mmol/l

0.61

140

(3035285) Chloride [Moles/volume] in Venous blood

140

2.09

3.39

3.1

2.3

103.0

106.1

mmol/l

2.23

140

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.02

3.37

3.0

2.0

15.0

15.9

umol/l

—

(3022621) pH of Urine by Test strip

109

765

1.46

3.36

4.8

2.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

2.34

3.34

1.5

1.1

promille

0.03

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

115

2.19

3.29

3.9

3.6

—

(4281824)

135

2.10

3.29

1.2

—

(3044927) Protein electrophoresis panel - Urine

135

2.10

3.29

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

941

0.62

3.27

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

3.35

3.19

1.6

1.3

3.5

3.1

mmol/l

0.24

(3052592) Norovirus Ag [Presence] in Stool

5.36

3.19

1.3

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.97

3.14

3.0

2.0

65.0

52.6

ug/l

0.26

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.02

3.05

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.02

3.05

1.1

1.6

—

mmol/l

—

(4306422)

182

1.89

3.02

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.16

2.93

1.5

1.1

302.3

301.9

pmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

128

2.05

2.92

1.7

2.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.84

2.92

1.8

2.0

4808.6

38616.7

e6/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

192

1.84

2.90

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.71

2.89

1.1

1.2

340.0

233.3

iu/ml

0.33

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.20

2.84

1.5

1.2

0.4

0.7

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

179

1.86

2.83

1.0

1.1

—

(3048879) Bone marrow aspiration report

3.07

2.81

1.1

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.48

2.79

1.1

ratio

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

180

1.85

2.79

1.7

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1232

11828

1.27

2.76

4.8

4.0

1.7

1.3

mmol/l

40.93

1075

10847

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.87

2.75

3.8

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

294

1.65

2.74

3.0

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

389

1.57

2.73

2.0

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

140

1811

0.75

2.71

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.25

2.71

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

273

1.67

2.67

3.0

1.9

—

(3033799) Differential panel - Peritoneal fluid

2.81

2.65

3.1

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

1126

1.33

2.62

2.7

2.4

29.4

40.3

u/l

1.48

113

987

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.27

2.61

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.68

2.60

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.31

2.58

1.6

1.1

—

(40768806) Pleura Pathology biopsy report

121

2.00

2.56

1.7

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

135

1.94

2.56

3.3

2.3

—

(3045424) Erythrocytes [Presence] in Urine

202

1.75

2.50

1.4

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.83

2.48

1.0

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.39

2.47

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.39

2.47

1.0

1.1

111.0

93.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

166

1.82

2.46

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

296

1.61

2.44

2.9

1.9

—

(3028300) Cannabinoids [Presence] in Urine

297

1.60

2.41

3.2

1.9

—

(3044007) Cell count panel - Peritoneal fluid

2.76

2.37

3.1

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.27

2.37

4.0

7.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

105

784

1.37

2.35

1.4

—

(40768441) Liver Pathology biopsy report

2.16

2.35

2.1

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

388

1.52

2.34

1.6

2.2

95.4

90.6

0.70

366

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.06

2.32

2.6

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

2.19

2.31

1.4

1.3

11.1

12.6

mmol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

606

1.41

2.31

1.9

3.5

32.5

55.4

u/ml

1.21

586

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

253

2126

1.23

2.29

1.3

1.2

28.8

30.5

iu/ml

0.10

711

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

245

2053

1.23

2.28

3.6

2.7

1.4

1.0

e6/l

1.20

143

1164

(40768800) Prostate Pathology biopsy report

273

0.43

2.28

1.4

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.35

2.22

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.18

2.15

1.6

1.1

—

(3049717) Cytology report of Urine Cyto stain

481

1.43

2.10

1.9

2.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.04

2.06

1.4

2.1

12.7

15.1

—

(3011412) CD3 cells [#/volume] in Blood

118

1.88

2.02

2.2

1.2

1.1

e9/l

0.14

(3002256) Pathology report gross observation

193

1604

1.23

1.95

1.2

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

2.36

1.95

2.8

12.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.56

1.94

1.2

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.76

1.93

1.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.74

1.93

1.2

—

(3027944) Amphetamines [Presence] in Urine

291

1.53

1.91

3.2

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

308

1.51

1.89

1.4

1.3

—

(40761535) Cells panel - Urine sediment

126

1002

1.28

1.86

4.1

3.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.58

1.80

1.1

—

(3045788) Cell count panel - Pleural fluid

109

1.85

1.77

1.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.94

1.75

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

1.74

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.34

1.74

1.2

1.3

0.8

1.6

mmol/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.23

1.74

1.8

2.4

396.7

881.8

e6/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

186

1.63

1.73

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

536

1.36

1.71

2.1

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

148

1.70

1.71

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

310

2729

1.17

1.70

4.4

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

326

2883

1.17

1.69

3.0

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.81

1.65

1.0

1.2

—

(4035726)

137

1121

1.25

1.62

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.15

1.61

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.15

1.61

1.1

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.15

1.61

1.8

3.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.21

1.57

1.0

12.5

79.3

65.9

mg/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

236

2047

1.18

1.55

1.3

1.2

13.7

12.8

u/ml

0.05

815

(3028717) Thiamine [Mass/volume] in Blood

3.34

1.52

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

1.52

1.6

2.9

0.8

0.7

u/field

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1286

12557

1.21

1.52

5.9

4.9

2.4

2.8

mmol/l

51.65

1140

11591

(3025130) Human papilloma virus identified in Specimen

126

0.39

1.50

1.4

1.9

—

(3036489) Thrombin time

471

1.35

1.49

1.7

2.0

21.7

21.5

0.12

420

(3051387) C reactive protein [Mass/volume] in Capillary blood

260

1.47

8.2

3.9

26.5

23.8

mg/l

0.16

166

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.88

1.45

1.4

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.12

1.44

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.13

1.44

10.4

5.1

4.7

6.0

mmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

196

1.54

1.43

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.95

1.38

1.3

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1339

13147

1.23

1.35

16.2

10.4

28.7

26.5

u/l

2.65

1289

12715

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

183

1.54

1.35

1.1

1.2

6.4

3.6

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

471

1.33

1.34

1.3

23.7

33.9

iu/l

1.98

409

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

350

1.38

1.34

1.3

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1057

10201

1.13

1.33

37.0

16.9

15.0

13.7

82.24

1033

9968

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

176

1513

1.19

1.31

14.1

6.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

352

1.38

1.30

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.51

1.30

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.51

1.30

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.10

1.30

2.2

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

134

0.45

1.28

2.7

1.5

—

(4211845)

2.05

1.27

2.2

2.8

—

(3052851) Hemolysis interference index of Serum or Plasma

380

1.35

1.26

4.8

3.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

355

1.36

1.25

1.3

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

131

1.61

1.24

1.2

1.3

26.8

32.1

u/l

0.41

104

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

409

0.68

1.24

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

139

1.59

1.23

1.1

1.2

104.2

97.2

0.51

132

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.97

1.22

1.2

—

17.1

u/ml

—

(3028433) Virus identified in Specimen by Culture

2.17

1.21

1.6

1.4

—

(3006462) Nitrate [Presence] in Urine

2.17

1.21

2.3

3.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.17

1.21

1.8

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

143

0.49

1.21

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

359

0.66

1.20

1.4

1.5

—

(3011648) Oxygen content in Venous blood

101

1.69

1.20

1.7

1.9

11.5

10.7

0.29

101

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

358

1.35

1.19

1.8

1.6

0.1

iu/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

127

0.47

1.17

1.8

1.5

—

(3051651) Icteric interference index of Serum or Plasma

1.73

1.15

3.4

4.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1259

12325

1.16

1.15

5.4

4.4

4.2

4.7

mmol/l

60.16

1113

11450

(3032057) Clostridioides difficile [Presence] in Stool

2.39

1.09

1.2

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.82

1.09

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.19

1.08

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.06

1.03

1.4

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1249

12241

1.14

1.02

5.4

4.4

1.2

1.5

mmol/l

83.48

1101

11295

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.66

1.00

3.2

2.0

2.1

2.5

u/field

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.77

1.00

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.80

0.96

1.0

2.0

23.8

182.5

ug/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.90

0.94

1.7

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

119

0.50

0.94

1.8

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

119

0.50

0.94

1.8

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

120

0.50

0.93

1.8

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

120

0.50

0.93

1.8

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

1.57

0.90

1.3

1.1

—

36.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

185

1.41

0.89

1.1

1.2

3.6

6.8

u/ml

0.84

(3003740) Influenza virus B Ag [Presence] in Specimen

177

1.42

0.88

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

351

1.29

0.88

1.6

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

115

992

1.17

0.88

4.3

2.5

50.9

67.2

ml/min/173m2

3.97

396

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

103

1.56

0.87

1.3

1.1

—

55.2

—

(3034426) Prothrombin time (PT)

1.87

0.87

1.0

1.4

—

(40768446) Kidney Pathology biopsy report

1.87

0.87

1.4

1.6

—

(3022689) Creatine [Moles/volume] in Urine

2.00

0.87

1.0

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.67

0.85

1.1

—

(3008898) HLA-B27 [Presence]

411

0.75

0.84

1.1

—

(3023410) Appearance of Cerebral spinal fluid

141

0.57

0.82

1.4

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.88

0.82

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.88

0.82

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.88

0.82

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.88

0.82

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

148

1311

1.14

0.81

2.8

4.2

38.2

22.3

ug/l

0.26

119

1074

(21494814) CD8 cells/100 lymphocytes in Specimen

1.71

0.80

1.9

1.8

—

(3016228) CD19 cells/100 cells in Blood

1.71

0.80

1.9

1.8

9.6

7.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.78

0.0

3.1

—

36.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.51

0.78

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

124

0.56

0.78

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.77

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.76

0.0

1.0

—

34.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.09

0.74

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

150

1.41

0.73

1.8

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

281

1.29

0.73

3.8

4.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

0.55

0.72

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.62

0.71

1.3

1.5

—

(40768795) Lymph node Pathology biopsy report

134

1.42

0.71

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.75

0.71

2.4

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.75

0.71

3.9

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

790

0.84

0.69

1.1

1.3

—

(3000330) Specific gravity of Urine by Test strip

575

1.19

0.69

3.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.53

0.69

2.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

178

1.35

0.69

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.85

0.68

1.0

2.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

643

1.18

0.66

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.54

0.65

2.9

1.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.59

0.62

1.1

2.8

681.1

1381.8

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

147

1.37

0.62

1.2

1.3

8.8

7.5

mmol/l

0.81

106

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

130

1.39

0.61

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.48

0.60

1.1

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.60

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

163

0.67

0.60

1.2

1.0

7.9

5.3

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.59

0.0

1.9

—

(44806420)

1.62

0.55

1.2

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

122

0.65

0.55

2.3

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

317

0.78

0.54

1.4

1.7

—

(3042733) HLA Ab [Presence] in Serum

1.58

0.54

2.3

4.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.50

0.54

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

157

0.70

0.51

1.1

0.5

2.1

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.47

0.50

1.0

—

0.5

u/ml

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.47

0.50

2.0

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

298

0.80

0.46

1.2

1.4

8.4

28.2

e6/l

0.56

233

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

118

0.68

0.46

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

403

4201

0.94

0.44

4.0

4.8

2.1

2.7

ug/l

0.64

340

3792

(3017704) Immunofixation for Urine

1.41

0.43

1.3

1.7

—

(1002224) Polysomnography panel

509

1.15

0.43

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

230

1.22

0.42

1.2

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

184

0.76

0.42

1.1

0.5

2.0

u/ml

—

(3015183) Erythrocyte sedimentation rate

1.38

0.41

1.4

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.4

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.36

0.41

1.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

114

1.32

0.40

2.3

3.6

58.9

48.0

u/ml

0.14

114

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

27.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.40

0.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.40

0.0

5.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.31

0.39

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.43

0.39

1.2

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

8.7

—

0.4

—

(4268621)

124

1.29

0.38

2.0

2.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.39

0.38

1.0

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.35

0.37

2.2

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

235

0.81

0.37

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

134

1.27

0.37

3.8

—

(4094501)

363

0.85

0.35

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

339

1.15

0.34

1.4

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

329

0.85

0.34

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

403

0.87

0.33

1.2

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

210

1.19

0.32

1.2

1.5

104.0

134.7

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

791

1.09

0.31

1.1

1.2

172.2

138.8

iu/ml

0.16

306

(3017446) Testosterone [Moles/volume] in Serum or Plasma

871

0.91

0.31

3.2

2.2

9.3

13.2

nmol/l

4.48

777

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.72

0.31

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

218

0.82

0.30

1.1

1.2

369.5

283.8

u/ml

—

131

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

335

1.14

0.29

1.3

1.2

—

31.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

317

1.14

0.28

1.3

1.2

5.0

9.0

u/ml

—

(44813793)

1.32

0.28

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.29

0.28

1.5

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

1128

11168

1.04

0.28

31.2

15.0

39.4

39.9

0.71

573

8047

(3014051) Protein [Presence] in Urine by Test strip

271

1.15

0.27

2.9

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

188

1798

1.05

0.25

1.5

1.4

—

(3010813) Leukocytes [#/volume] in Blood

1358

13640

0.94

0.24

48.3

20.4

8.0

6.6

e9/l

76.02

1326

13257

(3019897) Erythrocyte distribution width [Ratio] by Automated count

147

0.81

0.23

3.3

2.0

13.7

13.2

1.07

147

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

458

1.09

0.22

1.0

1.1

—

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

178

0.84

0.22

1.5

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

305

1.12

0.22

2.1

1.8

30.1

40.6

nmol/l

2.97

293

(3019150) Specific gravity of Urine by Refractometry

265

2567

1.04

0.21

6.0

3.9

1.0

kg/l

0.10

368

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.19

0.21

1.0

1.3

7.0

9.0

ug/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(36660697) Celiac disease serology panel - Serum

897

1.06

0.21

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

547

1.08

0.21

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

872

0.94

0.21

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.20

0.0

1.7

—

(3019174) dRVVT (LA screen)

0.00

0.20

0.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

2.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

155

0.84

0.20

1.1

11.2

2.4

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

1359

13642

0.94

0.20

48.8

20.4

132.7

135.9

g/l

9.72

1343

13436

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

479

0.92

0.20

2.1

3.4

1690.0

2972.4

u/ml

0.22

412

(3026361) Erythrocytes [#/volume] in Blood

1359

13639

0.95

0.18

48.1

20.3

4.6

4.5

e12/l

3.06

1331

13252

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

128

1.17

0.18

1.3

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

204

1.13

0.18

1.5

1.6

—

(3035941) MCH [Entitic mass]

1359

13638

0.95

0.18

47.9

20.2

29.4

30.4

48.46

1343

13435

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.19

0.18

1.0

—

(3024731) MCV [Entitic volume]

1359

13637

0.95

0.17

48.0

20.3

91.1

91.2

0.46

1343

13437

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.22

0.17

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

129

1.16

0.17

1.3

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.73

0.17

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

152

0.85

0.17

1.4

1.8

—

528.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.13

0.15

1.1

1.2

21.0

6.0

u/l

—

(3007461) Platelets [#/volume] in Blood

1359

13632

0.95

0.15

48.2

20.4

254.3

250.0

e9/l

1.51

1334

13288

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.19

0.14

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.19

0.14

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.19

0.14

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

110

0.82

0.13

2.6

5.0

—

52.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

190

0.89

0.13

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

314

0.92

0.13

1.1

—

(4034850)

386

1.06

0.11

27.5

10.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

588

0.95

0.11

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

0.90

0.11

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

136

0.88

0.11

1.2

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

156

0.90

0.10

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.11

0.09

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.14

0.09

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.79

0.08

1.0

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.79

0.08

1.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.78

0.08

1.6

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

195

0.92

0.08

1.1

—

11.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.05

0.08

1.3

1.4

—

(3005570) Glucose [Moles/volume] in Urine

133

0.90

0.07

2.2

2.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.82

0.07

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

503

4988

1.01

0.07

2.1

—

(3045142) Bone marrow Pathology biopsy report

153

0.91

0.07

1.1

1.3

—

(21494434) Karyotype in Bone marrow

122

0.90

0.07

1.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

0.86

0.06

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

314

0.95

0.05

1.3

1.2

74.8

202.6

miu/ml

—

145

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

212

0.94

0.05

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

657

1.02

0.03

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

321

3192

1.01

0.03

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

782

0.98

0.03

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

390

1.03

0.02

2.4

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

319

0.97

0.02

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

302

1.03

0.02

2.3

2.0

2.8

4.7

iu/l

—

101

(40768793) Breast Pathology biopsy report

283

1.03

0.01

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

265

0.98

0.00

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

135

0.96

0.00

1.0

0.4

2.2

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

125

0.96

0.00

1.0

1.1

2.2

3.0

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

115

1.04

0.00

1.5

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(4024509)

0.93

0.00

1.6

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

4.0

—

12.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.95

0.00

2.4

6.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.8

1.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

18.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.92

0.00

1.0

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.98

0.00

1.6

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

402.0

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

23.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.9

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.7

—

8.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

185.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

37.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.8

—

2.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(4027681)

0.96

0.00

1.5

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

8.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYXTRMALV and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.928 [4.15, 5.85]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.785

During the follow-up period (1.1.1998 — 31.12.2019), 1150 out of 3720 females with E4_OBESITYXTRMALV died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYXTRMALV	4.648 [3.91, 5.52]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1186 out of 3284 males with E4_OBESITYXTRMALV died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYXTRMALV.

N-year risk	Females	Males
1	0.708%	0.697%
5	3.189%	4.419%
10	7.568%	11.367%
15	13.934%	20.929%
20	25.508%	33.412%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYXTRMALV – Extreme obesity with alveolar hypoventilation

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Extreme obesity with alveolar hypoventilation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints